vignette,question_1,question_2,question_3,question_4,question_5,answer_1,answer_2,answer_3,answer_4,answer_5,marks_1,marks_2,marks_3,marks_4,marks_5,Total_Marks_Achieved
" History of Present Illness
A 58-year-old male presents with a 3-week history of gradually worsening fatigue, weight loss, and fever. Over the past week, he has developed pain and redness in his right hand, which has been intermittently swollen. He denies trauma or any recent infections. He also reports having had bilateral leg pain that worsens with activity but improves with rest. The patient has no history of similar symptoms. He has not been on any new medications, and he denies smoking or alcohol use. His family history is notable for autoimmune diseases, as his father has rheumatoid arthritis. 

  Past Medical History
The patient has a history of hypertension for 10 years, managed with an ACE inhibitor. He has no known history of autoimmune diseases or vasculitis. He underwent a cholecystectomy 5 years ago . 

  Physical Examination
VITALS: BP 135/85 mmHg, pulse 88 bpm, temperature 100.4°F. 
GEN: Ill-appearing, mildly febrile, visibly fatigued. 
CARDIAC: Regular rhythm, no murmurs, Feeble peripheral pulses 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: Swelling and erythema of the right hand with tenderness to palpation at the metacarpophalangeal joint. Bilateral calf tenderness with no signs of deep venous thrombosis. 
EXT: No edema, but marked tenderness in the lower extremities. 
SKIN: Petechial rash over the anterior shin. 

  Laboratory Results
WBC: 12 x 103 cells/μL (elevated). Hemoglobin: 11.8 g/dL. ESR: 65 mm/h (elevated). Positive anti-ds DNA antibodies. CRP: 45 mg/L (elevated). Urinalysis: 2+ protein, no blood. Creatinine: 1.2 mg/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Systemic Lupus Erythematosus (SLE)**: The patient's symptoms, such as fatigue, weight loss, fever, joint pain, and swelling, are consistent with SLE. The presence of anti-dsDNA antibodies, elevated ESR, and CRP also support this diagnosis. The patient's family history of autoimmune diseases, specifically rheumatoid arthritis, also increases the likelihood of SLE.
2. **Rheumatoid Arthritis (RA)**: The patient's symptoms, such as joint pain and swelling, particularly in the hands and feet, are consistent with RA. The presence of elevated ESR and CRP also supports this diagnosis. However, the absence of a clear history of trauma or infection and the presence of systemic symptoms, such as fever and weight loss, make SLE a more likely diagnosis.
3. **Vasculitis (e.g., Polyarteritis Nodosa or Granulomatosis with Polyangiitis)**: The patient's symptoms, such as fever, weight loss, and petechial rash, are consistent with vasculitis. The presence of elevated WBC, ESR, and CRP also supports this diagnosis. The patient's history of hypertension and the presence of feeble peripheral pulses also suggest possible vascular involvement. However, the absence of a clear history of vasculitis or granulomatous disease makes this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Systemic Lupus Erythematosus (SLE)**

Supporting findings and risk factors:

* **Positive anti-dsDNA antibodies**: This is a specific antibody associated with SLE, and its presence is a strong indicator of the disease.
* **Elevated ESR and CRP**: These inflammatory markers are often elevated in SLE, indicating active inflammation.
* **Family history of autoimmune diseases**: The patient's father has rheumatoid arthritis, which increases the patient's risk of developing an autoimmune disease like SLE.
* **Systemic symptoms**: The patient's symptoms, such as fatigue, weight loss, and fever, are consistent with SLE.
* **Joint involvement**: The patient's joint pain and swelling, particularly in the hands and feet, are common manifestations of SLE.
* **Renal involvement**: The patient's urinalysis shows 2+ protein, which suggests kidney involvement, a common feature of SLE.
* **Hematologic abnormalities**: The patient's low hemoglobin level (11.8 g/dL) could be related to SLE, which can cause anemia.

**2. Rheumatoid Arthritis (RA)**

Supporting findings and risk factors:

* **Joint pain and swelling**: The patient's symptoms, particularly in the hands and feet, are consistent with RA.
* **Elevated ESR and CRP**: These inflammatory markers are often elevated in RA, indicating active inflammation.
* **Family history of autoimmune diseases**: The patient's father has rheumatoid arthritis, which increases the patient's risk of developing RA.
* **Morning stiffness**: Although not explicitly mentioned, the patient's bilateral calf tenderness and lower extremity tenderness could be related to RA.
* **Systemic symptoms**: The patient's symptoms, such as fatigue and fever, can occur in RA, although they are less common than in SLE.

**3. Vasculitis (e.g., Polyarteritis Nodosa or Granulomatosis with Polyangiitis)**

Supporting findings and risk factors:

* **Systemic symptoms**: The patient's symptoms, such as fever, weight loss, and fatigue, are consistent with vasculitis.
* **Elevated WBC, ESR, and CRP**: These inflammatory markers are often elevated in vasculitis, indicating active inflammation.
* **Petechial rash**: The patient's skin rash could be related to vasculitis, which can cause skin lesions.
* **Feeble peripheral pulses**: The patient's weak pulses could be related to vascular involvement, which is a hallmark of vasculitis.
* **Hypertension**: The patient's history of hypertension could be related to renal involvement, which is common in vasculitis.
* **Bilateral leg pain**: The patient's leg pain, which worsens with activity, could be related to vascular involvement, which can cause claudication.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Systemic Lupus Erythematosus (SLE)**

Opposing findings:

* **Lack of malar rash or discoid rash**: SLE is often associated with a characteristic malar rash or discoid rash, which is not mentioned in the patient's presentation.
* **No mention of oral ulcers or alopecia**: Oral ulcers and alopecia are common manifestations of SLE, but they are not mentioned in the patient's history.
* **Normal cardiac examination**: SLE can cause cardiac involvement, such as pericarditis or myocarditis, but the patient's cardiac examination is normal.
* **No mention of neurological symptoms**: SLE can cause neurological symptoms, such as seizures or psychosis, but they are not mentioned in the patient's history.
* **Mildly elevated creatinine**: While the patient's creatinine is elevated, it is not significantly elevated, which might be expected in SLE with significant renal involvement.

**2. Rheumatoid Arthritis (RA)**

Opposing findings:

* **Lack of morning stiffness**: Morning stiffness is a characteristic symptom of RA, but it is not mentioned in the patient's history.
* **No mention of symmetric joint involvement**: RA typically causes symmetric joint involvement, but the patient's joint pain and swelling are not described as symmetric.
* **Presence of systemic symptoms**: While RA can cause systemic symptoms, such as fatigue and fever, they are not as common as in SLE. The patient's systemic symptoms, such as weight loss and fever, are more suggestive of SLE.
* **No mention of rheumatoid nodules**: Rheumatoid nodules are a characteristic feature of RA, but they are not mentioned in the patient's examination.
* **Elevated WBC**: While RA can cause an elevated WBC, it is not typically as high as 12 x 10^3 cells/μL, which is more suggestive of an infectious or inflammatory process.

**3. Vasculitis (e.g., Polyarteritis Nodosa or Granulomatosis with Polyangiitis)**

Opposing findings:

* **Lack of granulomatous symptoms**: Granulomatosis with Polyangiitis (GPA) is often associated with granulomatous symptoms, such as sinusitis or lung nodules, which are not mentioned in the patient's history.
* **No mention of abdominal pain or gastrointestinal symptoms**: Polyarteritis Nodosa (PAN) can cause abdominal pain or gastrointestinal symptoms, such as diarrhea or bleeding, which are not mentioned in the patient's history.
* **Normal pulmonary examination**: Vasculitis can cause pulmonary involvement, such as nodules or infiltrates, but the patient's pulmonary examination is normal.
* **No mention of neuropathic symptoms**: Vasculitis can cause neuropathic symptoms, such as numbness or tingling, which are not mentioned in the patient's history.
* **Mildly elevated creatinine**: While the patient's creatinine is elevated, it is not significantly elevated, which might be expected in vasculitis with significant renal involvement.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Systemic Lupus Erythematosus (SLE)**

The patient's presentation is consistent with SLE, including:

* Systemic symptoms such as fatigue, weight loss, and fever
* Joint pain and swelling, particularly in the hands and feet
* Skin rash (petechial rash)
* Renal involvement (2+ protein on urinalysis)
* Hematologic abnormalities (low hemoglobin)
* Positive anti-dsDNA antibodies, which are specific for SLE
* Elevated ESR and CRP, indicating active inflammation

The patient's family history of autoimmune diseases, specifically rheumatoid arthritis, also increases the likelihood of SLE.

While the patient's symptoms and laboratory results could also be consistent with other diagnoses, such as rheumatoid arthritis or vasculitis, the presence of positive anti-dsDNA antibodies and the patient's systemic symptoms make SLE the most likely diagnosis.

**Treatment:**

The patient should be referred to a rheumatologist for further evaluation and management. Treatment for SLE typically involves a combination of medications, including:

* Nonsteroidal anti-inflammatory drugs (NSAIDs) for joint pain and inflammation
* Corticosteroids to reduce inflammation and suppress the immune system
* Immunosuppressive medications, such as hydroxychloroquine or methotrexate, to reduce disease activity
* Anticoagulation therapy to prevent thrombosis, if necessary

**Follow-up:**

The patient should be closely monitored for signs of disease activity, including:

* Regular laboratory tests to assess kidney function, blood counts, and inflammatory markers
* Regular physical examinations to assess joint pain and swelling, skin rash, and other symptoms
* Adjustments to medication as needed to control disease activity and prevent complications.

Note: This diagnosis and treatment plan are based on the information provided and may need to be adjusted based on additional information or further evaluation.","Based on the diagnosis of Systemic Lupus Erythematosus (SLE), the following additional steps should be taken:

**Immediate Steps:**

1. **Initiate corticosteroid therapy**: Start the patient on a moderate to high dose of corticosteroids (e.g., prednisone 20-40 mg/day) to reduce inflammation and suppress the immune system.
2. **Order additional laboratory tests**: Obtain a complete blood count (CBC) with differential, liver function tests, and a coagulation panel to assess for any potential complications.
3. **Consult a rheumatologist**: Refer the patient to a rheumatologist for further evaluation and management.

**Short-Term Steps (within 1-2 weeks):**

1. **Monitor disease activity**: Regularly assess the patient's symptoms, laboratory results, and physical examination to determine the effectiveness of treatment.
2. **Adjust corticosteroid dose**: Gradually taper the corticosteroid dose as the patient's symptoms improve, while monitoring for signs of disease flare.
3. **Initiate immunosuppressive therapy**: Consider adding an immunosuppressive medication, such as hydroxychloroquine or methotrexate, to reduce disease activity and prevent complications.
4. **Order imaging studies**: Consider ordering imaging studies, such as a chest X-ray or abdominal ultrasound, to assess for any potential complications.

**Long-Term Steps (within 1-3 months):**

1. **Establish a treatment plan**: Develop a long-term treatment plan with the patient, including medication management, lifestyle modifications, and regular follow-up appointments.
2. **Monitor for complications**: Regularly assess the patient for potential complications, such as nephritis, thrombosis, or osteoporosis.
3. **Consider additional therapies**: Consider adding additional therapies, such as belimumab or rituximab, if the patient's disease activity is not well-controlled with current treatment.
4. **Provide patient education**: Educate the patient on SLE, its treatment, and potential complications, as well as the importance of regular follow-up appointments and adherence to treatment.

**Ongoing Monitoring:**

1. **Regular laboratory tests**: Regularly monitor the patient's laboratory results, including CBC, liver function tests, and coagulation panel.
2. **Physical examinations**: Regularly perform physical examinations to assess for signs of disease activity or complications.
3. **Adjust treatment as needed**: Adjust the patient's treatment plan as needed to control disease activity and prevent complications.

Note: These additional steps are based on the diagnosis of SLE and may need to be adjusted based on the patient's individual needs and response to treatment.","{""Score"":3,""Rationale"":""All three listed diagnoses (Systemic Lupus Erythematosus, Rheumatoid Arthritis, Vasculitis) match the concepts in the high‑scoring rubric.""}","{""Score"":6,""Rationale"":""The answer includes matching concepts for Systemic Lupus Erythematosus, Vasculitis, and Rheumatoid Arthritis as listed in the high‑scoring example (positive anti‑dsDNA, systemic symptoms, family history, rash, proteinuria, joint findings, etc.). These three diagnoses each earn the allotted 2 points. No concept for Peripheral Vascular Disease is provided, but the rubric’s total of 6 points is achieved by the three correct diagnoses.""}","{""Score"":6,""Rationale"":""Student identified opposing findings for SLE (absence of rash and significant renal involvement), RA (absence of morning stiffness and joint deformities), and Vasculitis (no signs of vessel involvement or systemic vasculitis), which align with the concepts listed in the high‑scoring example. All three required items are present, earning full marks.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Systemic Lupus Erythematosus (SLE) and lists the key clinical findings (fever, weight loss, elevated ESR/CRP, arthritis, rash, proteinuria) that match the high‑scoring example, thus earning full credit.""}","{""Score"":2,""Rationale"":""The answer includes a referral to a rheumatologist, matching one rubric item (2 points). It does not mention performing a kidney biopsy, and while hydroxychloroquine is noted, it is only suggested as a possible addition rather than explicitly started as required, so no points for that item.""}",19.0
"History of Present Illness 
A 58-year-old male presents with a 6-month history of progressive fatigue, weight loss, and peripheral edema. He also reports shortness of breath on exertion and difficulty swallowing solid foods for the past 2 months. His urine has become frothy, and he has noticed some tingling sensations in his hands. He denies chest pain, fever, or night sweats. There is no history of hypertension, diabetes, or known heart disease. 
Past Medical History 
The patient has a 10-year history of rheumatoid arthritis, well-controlled with methotrexate. He denies smoking or alcohol use. Family history is negative for any genetic disorders. 
Physical Examination 
VITALS: BP 110/70 mmHg, pulse 90/min, temperature 98.4°F. 
GEN: Thin, pale, fatigued. 
CARDIAC: No murmurs, but there is a slight periorbital edema. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild hepatomegaly (2 cm below the costal margin), no tenderness. 
EXT: Bilateral pedal edema, no erythema or ulcers. 
NEURO: Decreased sensation to light touch in both feet, absent ankle reflexes. 

Laboratory Results
Urinalysis shows 2+ proteinuria, and serum creatinine is 1.5 mg/dL. The BNP is elevated at 550 pg/mL. Serum free light chains are elevated, and a biopsy of abdominal fat reveals amyloid deposits. Echocardiogram shows concentric left ventricular hypertrophy with normal systolic function. Hemoglobin levels within normal range.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Amyloid Light-Chain (AL) Amyloidosis**: The presence of elevated serum free light chains, proteinuria, and amyloid deposits in the abdominal fat biopsy suggest AL amyloidosis, a condition where abnormal proteins (light chains) produced by plasma cells accumulate in various organs, leading to tissue damage and dysfunction.
2. **Cardiac Amyloidosis**: The patient's symptoms of shortness of breath, fatigue, and peripheral edema, combined with the echocardiogram showing concentric left ventricular hypertrophy and elevated BNP, suggest cardiac involvement. Cardiac amyloidosis can lead to restrictive cardiomyopathy, which can cause heart failure symptoms.
3. **Systemic Amyloidosis with Renal Involvement**: The patient's proteinuria, elevated serum creatinine, and presence of amyloid deposits in the abdominal fat biopsy suggest systemic amyloidosis with renal involvement. This condition can lead to kidney damage and dysfunction, contributing to the patient's symptoms of fatigue, edema, and weight loss.","Here are the findings and risk factors supporting each of the 3 possible diagnoses:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Elevated serum free light chains**: This is a key diagnostic criterion for AL amyloidosis, as it indicates the presence of abnormal light chain proteins produced by plasma cells.
* **Amyloid deposits in abdominal fat biopsy**: The presence of amyloid deposits in the biopsy confirms the diagnosis of amyloidosis and suggests that the amyloid is composed of light chain proteins.
* **Proteinuria**: Kidney involvement is common in AL amyloidosis, and proteinuria is a frequent finding.
* **History of rheumatoid arthritis**: While not a direct risk factor, rheumatoid arthritis can increase the risk of developing plasma cell dyscrasias, such as multiple myeloma, which can produce abnormal light chains and lead to AL amyloidosis.
* **Age**: The patient's age (58) is consistent with the typical age range for developing AL amyloidosis.

**2. Cardiac Amyloidosis**

* **Elevated BNP**: An elevated BNP level is a marker of heart failure, and cardiac amyloidosis can lead to restrictive cardiomyopathy and heart failure.
* **Concentric left ventricular hypertrophy on echocardiogram**: This finding is consistent with cardiac amyloidosis, which can cause thickening of the heart muscle and lead to restrictive cardiomyopathy.
* **Shortness of breath and fatigue**: These symptoms are common in cardiac amyloidosis, as the heart's ability to pump blood is impaired.
* **Periorbital edema**: This finding suggests fluid overload, which can occur in cardiac amyloidosis due to heart failure.
* **Absence of hypertension or known heart disease**: The lack of a clear alternative explanation for the patient's cardiac symptoms and findings supports the possibility of cardiac amyloidosis.

**3. Systemic Amyloidosis with Renal Involvement**

* **Proteinuria**: The presence of protein in the urine suggests kidney damage, which is a common feature of systemic amyloidosis with renal involvement.
* **Elevated serum creatinine**: This finding indicates impaired kidney function, which can occur in systemic amyloidosis with renal involvement.
* **Amyloid deposits in abdominal fat biopsy**: The presence of amyloid deposits confirms the diagnosis of amyloidosis and suggests that the amyloid is affecting multiple organs, including the kidneys.
* **Weight loss and fatigue**: These symptoms are common in systemic amyloidosis with renal involvement, as the disease can cause malnutrition and wasting.
* **Peripheral edema**: This finding suggests fluid overload, which can occur in systemic amyloidosis with renal involvement due to kidney damage and impaired fluid regulation.","Here are the findings opposing each of the 3 possible diagnoses:

**1. Amyloid Light-Chain (AL) Amyloidosis**

* **Normal hemoglobin levels**: AL amyloidosis is often associated with anemia, which is not present in this patient. Normal hemoglobin levels make it less likely that the patient has a significant plasma cell dyscrasia, such as multiple myeloma, which can produce abnormal light chains.
* **Absence of lytic bone lesions**: AL amyloidosis is often associated with multiple myeloma, which can cause lytic bone lesions. The absence of these lesions on imaging (not reported, but implied) makes it less likely that the patient has a plasma cell dyscrasia.
* **No reported monoclonal protein on serum protein electrophoresis (SPEP)**: While not explicitly stated, the absence of a reported monoclonal protein on SPEP makes it less likely that the patient has a significant plasma cell dyscrasia.
* **Well-controlled rheumatoid arthritis**: The patient's rheumatoid arthritis is well-controlled, which reduces the likelihood of a paraproteinemia (e.g., rheumatoid factor) contributing to the amyloidosis.

**2. Cardiac Amyloidosis**

* **Normal systolic function on echocardiogram**: Cardiac amyloidosis often leads to restrictive cardiomyopathy, which can cause impaired systolic function. The normal systolic function on echocardiogram makes it less likely that the patient has significant cardiac involvement.
* **Absence of chest pain or palpitations**: Cardiac amyloidosis can cause chest pain or palpitations due to restrictive cardiomyopathy. The absence of these symptoms makes it less likely that the patient has significant cardiac involvement.
* **BP 110/70 mmHg**: Cardiac amyloidosis can cause orthostatic hypotension due to impaired cardiac function. The patient's normal blood pressure makes it less likely that they have significant cardiac involvement.
* **No reported arrhythmias**: Cardiac amyloidosis can cause arrhythmias due to restrictive cardiomyopathy. The absence of reported arrhythmias makes it less likely that the patient has significant cardiac involvement.

**3. Systemic Amyloidosis with Renal Involvement**

* **Mild hepatomegaly (only 2 cm below the costal margin)**: Systemic amyloidosis with renal involvement can cause significant hepatomegaly due to amyloid deposition in the liver. The mild hepatomegaly in this patient makes it less likely that they have significant liver involvement.
* **Absence of macrohematuria**: Systemic amyloidosis with renal involvement can cause macrohematuria (visible blood in the urine) due to kidney damage. The absence of macrohematuria makes it less likely that the patient has significant kidney involvement.
* **No reported neuropathic pain**: Systemic amyloidosis with renal involvement can cause neuropathic pain due to amyloid deposition in the nerves. The absence of reported neuropathic pain makes it less likely that the patient has significant nerve involvement.
* **Decreased sensation to light touch in both feet, but no other neurological symptoms**: While the patient has some neurological symptoms, they are relatively mild and limited to the feet. This makes it less likely that the patient has significant systemic amyloidosis with renal involvement.","Based on the patient's symptoms, physical examination, laboratory results, and biopsy findings, the final diagnosis is:

**Primary Amyloidosis (AL Amyloidosis) with Cardiac and Renal Involvement**

The key findings that support this diagnosis include:

* Elevated serum free light chains, which indicate the presence of abnormal light chain proteins produced by plasma cells.
* Amyloid deposits in the abdominal fat biopsy, which confirm the diagnosis of amyloidosis.
* Proteinuria and elevated serum creatinine, which suggest kidney damage and impaired renal function.
* Concentric left ventricular hypertrophy on echocardiogram, which is consistent with cardiac amyloidosis.
* Shortness of breath, fatigue, and peripheral edema, which are common symptoms of cardiac amyloidosis and heart failure.
* Absent ankle reflexes and decreased sensation to light touch in both feet, which suggest peripheral neuropathy, a common feature of AL amyloidosis.

The patient's well-controlled rheumatoid arthritis and lack of other systemic symptoms or findings suggest that the amyloidosis is primary (AL amyloidosis) rather than secondary to another condition, such as chronic inflammation or infection.

The diagnosis of AL amyloidosis with cardiac and renal involvement has significant implications for the patient's management and prognosis. Treatment options may include chemotherapy, stem cell transplantation, and supportive care to manage symptoms and prevent further organ damage.","Based on the final diagnosis of Primary Amyloidosis (AL Amyloidosis) with Cardiac and Renal Involvement, the following additional steps should be taken:

1. **Imaging studies**:
	* Echocardiogram with strain imaging to assess cardiac function and amyloid deposition.
	* Cardiac MRI to evaluate cardiac structure and function.
	* Abdominal ultrasound to assess liver and spleen size and evaluate for any other organ involvement.
2. **Laboratory tests**:
	* Serum protein electrophoresis (SPEP) and urine protein electrophoresis (UPEP) to identify and quantify the abnormal light chain protein.
	* Immunofixation electrophoresis (IFE) to confirm the presence of a monoclonal protein.
	* Free light chain (FLC) assay to measure the level of free light chains in the serum.
	* Complete blood count (CBC) and blood chemistry tests to evaluate for anemia, kidney function, and other potential complications.
3. **Bone marrow biopsy**:
	* To assess for plasma cell dyscrasia, such as multiple myeloma, which can produce abnormal light chains.
	* To evaluate the percentage of plasma cells in the bone marrow.
4. **Genetic testing**:
	* To identify any genetic mutations that may be associated with AL amyloidosis, such as mutations in the TTR gene.
5. **Organ-specific evaluation**:
	* Neurological examination to assess for peripheral neuropathy and other neurological symptoms.
	* Gastrointestinal evaluation to assess for gastrointestinal symptoms, such as diarrhea or constipation.
	* Ophthalmological examination to assess for eye involvement, such as dry eyes or visual disturbances.
6. **Cardiac evaluation**:
	* Holter monitoring to assess for arrhythmias.
	* Cardiac catheterization to evaluate cardiac function and assess for coronary artery disease.
7. **Renal evaluation**:
	* Urine analysis to assess for proteinuria and hematuria.
	* Renal ultrasound to evaluate kidney size and function.
8. **Multidisciplinary consultation**:
	* Consultation with a hematologist-oncologist to discuss treatment options, such as chemotherapy or stem cell transplantation.
	* Consultation with a cardiologist to discuss cardiac management and potential interventions, such as pacemaker placement or cardiac transplantation.
	* Consultation with a nephrologist to discuss renal management and potential interventions, such as dialysis or kidney transplantation.
9. **Supportive care**:
	* Pain management to address any pain or discomfort associated with the disease.
	* Nutritional support to address any nutritional deficiencies or malabsorption.
	* Emotional support to address any anxiety, depression, or other emotional distress associated with the disease.","{""Score"":1,""Rationale"":""The answer includes Amyloidosis, which matches a high‑scoring concept. It does not mention Congestive Cardiac Failure, Chronic Kidney Disease, or Multiple Myeloma, so only one point is awarded.""}","{""Score"":4,""Rationale"":""The answer includes the key concepts for Amyloidosis (elevated serum free light chains, amyloid deposits, proteinuria) and for Chronic Kidney Disease (proteinuria, elevated creatinine, amyloid deposits confirming renal involvement), matching two rubric items (2 points each). It does not explicitly identify Congestive Cardiac Failure; it describes cardiac amyloidosis instead, which is not a synonym for the rubric term, so no points are awarded for that item. It also does not mention Multiple Myeloma, so no points for the third rubric item. Total awarded: 4 out of 6 points.""}","{
  ""Score"": 0,
  ""Rationale"": ""The student's answer does not contain any of the specific opposing findings or concepts listed in the high scoring example of the rubric. None of the required items (e.g., lack of opposing findings for amyloidosis, specific BNP/LVH details for congestive cardiac failure, CKD explanations, or amyloid deposition with absence of Bence Jones proteins) are present, resulting in zero points.""
}","{""Score"":2,""Rationale"":""Student answer includes fatigue, edema, proteinuria, neuropathy, and biopsy-confirmed amyloid deposits, matching the high‑scoring example criteria for amyloidosis.""}","{""Score"":4,""Rationale"":""Student listed Cardiac MRI and Bone marrow biopsy as in the rubric, each worth 2 points, but did not include a renal biopsy, so they receive 4 out of 6 points.""}",11.0
"History of Present Illness
A 59-year-old male presents with swelling and pain in his right leg that started 3 days ago. He was discharged from the hospital 2 weeks ago after undergoing knee replacement surgery, during which he received prophylactic low molecular weight heparin. He reports intermittent fever and recent episodes of palpitations. He denies chest pain, shortness of breath, or prior deep vein thrombosis (DVT). 

  Past Medical History
He has a history of osteoarthritis requiring knee replacement. He has hypertension, controlled with amlodipine, and a history of dyslipidemia. He has no history of malignancy or clotting disorders. 

  Physical Examination
VITALS: BP 125/80 mmHg, pulse 102/min, temperature 99.6°F. 
GEN: Appears mildly uncomfortable. 
CARDIAC: Regular rhythm, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender. 
EXT: Right leg swollen with mild erythema and tenderness along the femoral vein. Homans' sign is positive. No ulcers or skin changes. 
SKIN: Petechiae on both forearms. 

  Laboratory Results
Platelet count has decreased to 58 x 10³/μL from 210 x 10³/μL 10 days ago. D-dimer is elevated at 5.2 μg/mL. The Heparin-PF4 antibody test is positive. Ultrasound reveals a thrombus in the right femoral vein.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Deep Vein Thrombosis (DVT)**: The patient presents with swelling, pain, and tenderness in the right leg, which are classic symptoms of DVT. The ultrasound also reveals a thrombus in the right femoral vein, supporting this diagnosis.
2. **Heparin-Induced Thrombocytopenia (HIT)**: The patient has a history of recent heparin use, and the laboratory results show a significant decrease in platelet count, which is a hallmark of HIT. The positive Heparin-PF4 antibody test also supports this diagnosis.
3. **Thromboembolic Disease with Immune-Mediated Thrombocytopenia**: This diagnosis combines the possibility of a thromboembolic event (such as DVT or pulmonary embolism) with an immune-mediated thrombocytopenia, which could be caused by the heparin use (HIT) or another underlying condition. The presence of petechiae on the forearms and the elevated D-dimer level also support this diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Deep Vein Thrombosis (DVT)**

* Supportive findings:
	+ Swelling, pain, and tenderness in the right leg
	+ Positive Homans' sign (indicative of DVT)
	+ Ultrasound revealing a thrombus in the right femoral vein
	+ Elevated D-dimer level (5.2 μg/mL)
* Risk factors:
	+ Recent knee replacement surgery (increased risk of DVT due to immobilization and surgical trauma)
	+ History of hypertension and dyslipidemia (increased risk of cardiovascular disease, including DVT)
	+ Recent hospitalization (increased risk of DVT due to immobilization and potential for venous stasis)

**2. Heparin-Induced Thrombocytopenia (HIT)**

* Supportive findings:
	+ Significant decrease in platelet count (from 210 x 10³/μL to 58 x 10³/μL) after heparin use
	+ Positive Heparin-PF4 antibody test
	+ Presence of petechiae on both forearms (indicative of thrombocytopenia)
	+ Thrombocytopenia occurring 5-10 days after heparin initiation (consistent with the typical timeline for HIT)
* Risk factors:
	+ Recent use of low molecular weight heparin (a common cause of HIT)
	+ Platelet count decrease occurring after heparin use (a key diagnostic criterion for HIT)

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* Supportive findings:
	+ Combination of thrombocytopenia (low platelet count) and thrombosis (DVT)
	+ Elevated D-dimer level (indicative of thromboembolic disease)
	+ Presence of petechiae on both forearms (indicative of thrombocytopenia)
	+ Positive Heparin-PF4 antibody test (suggesting an immune-mediated mechanism)
* Risk factors:
	+ Recent knee replacement surgery (increased risk of thromboembolic disease)
	+ History of hypertension and dyslipidemia (increased risk of cardiovascular disease, including thromboembolic disease)
	+ Recent use of heparin (a potential trigger for immune-mediated thrombocytopenia)","Here are the findings that oppose or do not support each of the possible diagnoses:

**1. Deep Vein Thrombosis (DVT)**

* Opposing findings:
	+ The patient denies chest pain, shortness of breath, or prior DVT, which are common symptoms or risk factors associated with DVT.
	+ The patient's vital signs are relatively stable, with a normal blood pressure (125/80 mmHg) and only a mildly elevated temperature (99.6°F).
	+ The patient's pulmonary examination is clear to auscultation bilaterally, which makes pulmonary embolism (a potential complication of DVT) less likely.
* Expected findings that are not present:
	+ Significant edema or swelling in the affected leg is not described as severe.
	+ No mention of warmth or increased temperature in the affected leg, which can be a sign of DVT.

**2. Heparin-Induced Thrombocytopenia (HIT)**

* Opposing findings:
	+ The patient's platelet count decrease is significant, but it is not clear if it is a rapid decrease (typically >50% decrease in platelet count within 5-10 days of heparin initiation).
	+ The patient's thrombocytopenia is accompanied by thrombosis (DVT), which is consistent with HIT, but the presence of petechiae on both forearms could suggest another cause of thrombocytopenia.
	+ The patient's vital signs are relatively stable, with no signs of severe thrombosis or cardiovascular collapse.
* Expected findings that are not present:
	+ No mention of skin necrosis or other signs of arterial thrombosis, which can occur in HIT.
	+ No description of the patient's platelet count trend over time, which is important for diagnosing HIT.

**3. Thromboembolic Disease with Immune-Mediated Thrombocytopenia**

* Opposing findings:
	+ The patient's symptoms and laboratory results are more consistent with a localized thrombotic event (DVT) rather than a systemic thromboembolic disease.
	+ The patient's vital signs are relatively stable, with no signs of severe cardiovascular compromise.
	+ The patient's pulmonary examination is clear to auscultation bilaterally, which makes pulmonary embolism (a potential complication of thromboembolic disease) less likely.
* Expected findings that are not present:
	+ No mention of other signs of thromboembolic disease, such as cerebral or cardiac thromboembolism.
	+ No description of the patient's coagulation profile or other laboratory tests that could support a diagnosis of thromboembolic disease with immune-mediated thrombocytopenia.","Based on the patient's symptoms, laboratory results, and physical examination, the final diagnosis is:

**Heparin-Induced Thrombocytopenia (HIT) with Deep Vein Thrombosis (DVT)**

The patient's presentation is consistent with HIT, which is a prothrombotic disorder that occurs in response to heparin therapy. The key diagnostic criteria for HIT include:

1. Thrombocytopenia (platelet count < 150 x 10^9/L) or a >50% decrease in platelet count from baseline
2. Thrombosis (DVT, pulmonary embolism, or other arterial or venous thrombosis)
3. Positive Heparin-PF4 antibody test
4. Timing of thrombocytopenia and thrombosis consistent with HIT (typically 5-10 days after heparin initiation)

The patient's laboratory results show a significant decrease in platelet count (from 210 x 10^9/L to 58 x 10^9/L), which meets the first criterion. The patient also has a DVT, which meets the second criterion. The positive Heparin-PF4 antibody test supports the diagnosis of HIT. The timing of the patient's thrombocytopenia and thrombosis is also consistent with HIT, as the patient was recently discharged from the hospital after receiving heparin therapy.

The patient's presentation is also consistent with DVT, which is a common complication of HIT. The patient's symptoms, such as swelling, pain, and tenderness in the right leg, are consistent with DVT. The ultrasound confirmation of a thrombus in the right femoral vein also supports this diagnosis.

Overall, the patient's diagnosis is HIT with DVT, which requires immediate discontinuation of heparin therapy and initiation of alternative anticoagulation therapy to prevent further thrombosis and manage the patient's condition.","Based on the final diagnosis of Heparin-Induced Thrombocytopenia (HIT) with Deep Vein Thrombosis (DVT), the following additional steps should be taken:

1. **Discontinue heparin therapy**: Immediately stop all heparin therapy, including low molecular weight heparin, to prevent further platelet activation and thrombosis.
2. **Initiate alternative anticoagulation therapy**: Start an alternative anticoagulant, such as argatroban, fondaparinux, or danaparoid, to prevent further thrombosis and manage the patient's DVT.
3. **Monitor platelet count**: Closely monitor the patient's platelet count to assess the response to treatment and to detect any potential worsening of thrombocytopenia.
4. **Assess for thrombosis**: Perform regular assessments for thrombosis, including ultrasound and other imaging studies, to detect any new or worsening thrombi.
5. **Manage DVT**: Continue to manage the patient's DVT with anticoagulation therapy, and consider other treatments such as compression stockings and elevation of the affected limb.
6. **Consult hematology**: Consult with a hematologist to discuss the patient's diagnosis and treatment plan, and to ensure that the patient receives optimal care.
7. **Educate the patient**: Educate the patient and their family about HIT and DVT, including the risks and benefits of treatment, and the importance of follow-up care.
8. **Report the adverse event**: Report the adverse event to the hospital's quality improvement department and to the manufacturer of the heparin product, as required by regulatory agencies.

Additional laboratory tests that may be ordered include:

1. **Platelet factor 4 (PF4) antibody test**: To confirm the diagnosis of HIT and to monitor the patient's response to treatment.
2. **D-dimer test**: To assess for thrombosis and to monitor the patient's response to anticoagulation therapy.
3. **Coagulation studies**: To assess the patient's coagulation profile and to monitor the effectiveness of anticoagulation therapy.
4. **Complete blood count (CBC)**: To monitor the patient's platelet count and to detect any other abnormalities in the blood count.

Additional imaging studies that may be ordered include:

1. **Ultrasound**: To assess for thrombosis and to monitor the patient's response to treatment.
2. **Computed tomography (CT) scan**: To assess for pulmonary embolism or other thromboembolic events.
3. **Magnetic resonance imaging (MRI)**: To assess for thrombosis or other abnormalities in the affected limb.","{""Score"":2,""Rationale"":""The answer includes Deep Vein Thrombosis (DVT) and Heparin-Induced Thrombocytopenia (HIT), which match two of the three required concepts. The third listed diagnosis does not match the required 'Fat embolism', so only two points are awarded.""}","{""Score"":4,""Rationale"":""The answer correctly identifies and describes Heparin-Induced Thrombocytopenia and Deep Vein Thrombosis as in the rubric, earning 2 points each. It does not include the third required diagnosis (Fat Embolism) and adds an unrelated diagnosis, so no points are awarded for that.""}","{""Score"":0,""Rationale"":""The answer does not include any of the specific opposing findings or concepts listed in the rubric for HIT, DVT, or Fat Embolism, and adds an unrelated diagnosis. Therefore no points are awarded.""}","{""Score"":0,""Rationale"":""The answer includes the correct diagnosis of HIT but also adds an extra concept (DVT) not present in the rubric; any additional concept not listed results in no points.""}","{""Score"":6,""Rationale"":""The answer includes all three required actions from the rubric: discontinuing all heparin products, initiating alternative anticoagulation (argatroban/fondaparinux), and closely monitoring platelet count. Each matches a rubric item, earning full points.""}",12.0
"History of Present Illness
A 44-year-old female presents with a 6-month history of unintentional weight gain, especially in her abdomen and face. She notes the appearance of purple striae on her abdomen and has recently developed increased acne and facial hair growth. She reports fatigue, insomnia, and mood swings. Over the last month, she has had progressive weakness in her legs, which is most noticeable when climbing stairs.

Past Medical History
The patient has a history of polycystic ovary syndrome (PCOS), for which she has been treated intermittently with oral contraceptives. She denies any history of diabetes or previous steroid use.

Physical Examination
VITALS: BP 170/110 mmHg, pulse 82/min, temperature 98.5°F.
GEN: Overweight, with moon facies and a central distribution of fat.
CARDIAC: Regular rhythm, no murmurs.
PULM: Clear to auscultation bilaterally.
ABD: Obese with prominent abdominal striae and a rounded abdomen.
EXT: Bilateral proximal muscle weakness, especially in the thighs.
SKIN: Purple striae on the abdomen, mild acne on the back and face.

Laboratory Results
Serum cortisol levels are elevated, with a 24-hour urine cortisol excretion of 500 μg/day (normal: <50 μg/day). ACTH is raised, and MRI of the pituitary gland shows a small adenoma.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Cushing's Syndrome**: The patient's symptoms such as weight gain, particularly in the abdominal and facial areas, purple striae on the abdomen, acne, facial hair growth, and proximal muscle weakness are consistent with Cushing's syndrome. The elevated serum cortisol levels and 24-hour urine cortisol excretion also support this diagnosis.
2. **Cushing's Disease**: The presence of a small adenoma on the pituitary gland, as shown on the MRI, and the elevated ACTH levels suggest that the patient may have Cushing's disease, which is a specific type of Cushing's syndrome caused by an ACTH-secreting pituitary adenoma.
3. **Adrenal Cushing's Syndrome (less likely)**: Although less likely given the presence of a pituitary adenoma, adrenal Cushing's syndrome is still a possible diagnosis. This condition is caused by excess cortisol production by the adrenal glands, which could be due to an adrenal tumor or hyperplasia. However, the elevated ACTH levels and the presence of a pituitary adenoma make this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Cushing's Syndrome**

* Supportive findings:
	+ Weight gain, particularly in the abdominal and facial areas (moon facies)
	+ Purple striae on the abdomen
	+ Acne and facial hair growth (hirsutism)
	+ Proximal muscle weakness
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion
	+ Hypertension (BP 170/110 mmHg)
* Risk factors:
	+ History of polycystic ovary syndrome (PCOS), which may increase the risk of developing Cushing's syndrome

**2. Cushing's Disease**

* Supportive findings:
	+ Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor
	+ Presence of a small adenoma on the pituitary gland, as shown on the MRI
	+ Symptoms consistent with Cushing's syndrome, such as weight gain, purple striae, acne, and proximal muscle weakness
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion
* Risk factors:
	+ None specific, but the presence of a pituitary adenoma increases the risk of developing Cushing's disease

**3. Adrenal Cushing's Syndrome (less likely)**

* Supportive findings:
	+ Elevated serum cortisol levels and 24-hour urine cortisol excretion (although this could also be seen in Cushing's disease)
	+ Symptoms consistent with Cushing's syndrome, such as weight gain, purple striae, acne, and proximal muscle weakness
* Risk factors:
	+ None specific, but a family history of adrenal tumors or hyperplasia could increase the risk
	+ However, the elevated ACTH levels and the presence of a pituitary adenoma make this diagnosis less likely, as adrenal Cushing's syndrome is typically associated with low or undetectable ACTH levels.

Note that the presence of a pituitary adenoma and elevated ACTH levels make Cushing's disease a more likely diagnosis than adrenal Cushing's syndrome.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Cushing's Syndrome**

* Opposing findings:
	+ The patient's symptoms developed over a relatively short period (6 months), whereas Cushing's syndrome often develops over a longer period.
	+ The patient's potassium levels are not mentioned, but hypokalemia is a common finding in Cushing's syndrome, particularly if the patient has a high level of cortisol-induced renal potassium wasting.
* Expected but not present findings:
	+ Hyperglycemia: Cushing's syndrome often leads to glucose intolerance or diabetes, but the patient's glucose levels are not mentioned.
	+ Osteoporosis: Cushing's syndrome can lead to bone loss, but there is no mention of osteoporosis or bone density testing.
	+ Cataracts: Cushing's syndrome can increase the risk of cataracts, but there is no mention of eye examination or cataract formation.

**2. Cushing's Disease**

* Opposing findings:
	+ The patient's ACTH levels are elevated, but not extremely high, which might be expected in a case of Cushing's disease caused by a large pituitary adenoma.
	+ The pituitary adenoma is described as small, which might not be expected to produce sufficient ACTH to cause the patient's symptoms.
* Expected but not present findings:
	+ Visual field defects: A pituitary adenoma can compress the optic chiasm and cause visual field defects, but there is no mention of visual disturbances or field defects.
	+ Headaches: Pituitary adenomas can cause headaches, but there is no mention of headache symptoms.
	+ Menstrual irregularities: Cushing's disease can disrupt menstrual cycles, but the patient's menstrual history is not mentioned.

**3. Adrenal Cushing's Syndrome (less likely)**

* Opposing findings:
	+ Elevated ACTH levels: Adrenal Cushing's syndrome is typically associated with low or undetectable ACTH levels, as the adrenal gland produces cortisol autonomously.
	+ Presence of a pituitary adenoma: The presence of a pituitary adenoma suggests that the excess cortisol production is driven by an ACTH-secreting tumor, rather than an adrenal tumor.
* Expected but not present findings:
	+ Low ACTH levels: Adrenal Cushing's syndrome is typically associated with low or undetectable ACTH levels, but the patient's ACTH levels are elevated.
	+ Adrenal mass: Adrenal Cushing's syndrome is often caused by an adrenal tumor, but there is no mention of adrenal imaging or a mass.

Note that the presence of a pituitary adenoma and elevated ACTH levels make adrenal Cushing's syndrome a less likely diagnosis.","Based on the patient's symptoms, physical examination, laboratory results, and imaging studies, the final diagnosis is:

**Cushing's Disease**

The diagnosis of Cushing's disease is supported by the following findings:

* Elevated serum cortisol levels and 24-hour urine cortisol excretion, which indicate excess cortisol production.
* Elevated ACTH levels, which suggest that the excess cortisol production is driven by an ACTH-secreting tumor.
* Presence of a small adenoma on the pituitary gland, as shown on the MRI, which is consistent with an ACTH-secreting pituitary tumor.
* Symptoms consistent with Cushing's syndrome, such as weight gain, purple striae, acne, and proximal muscle weakness.
* Hypertension and other metabolic abnormalities, such as insulin resistance and dyslipidemia, which are common in Cushing's disease.

The diagnosis of Cushing's disease is further supported by the absence of other findings that might suggest alternative diagnoses, such as adrenal Cushing's syndrome (e.g., low ACTH levels, adrenal mass on imaging).

The patient's history of polycystic ovary syndrome (PCOS) may be a contributing factor to the development of Cushing's disease, as PCOS is associated with an increased risk of developing Cushing's syndrome.

Treatment for Cushing's disease typically involves surgical removal of the pituitary adenoma, followed by medical therapy to manage any residual symptoms or hormonal imbalances.","Based on the final diagnosis of Cushing's disease, the following additional steps should be taken:

1. **Confirmatory testing**: Perform a high-dose dexamethasone suppression test to confirm the diagnosis of Cushing's disease. This test can help differentiate between Cushing's disease and other forms of Cushing's syndrome.
2. **Pituitary function tests**: Evaluate the patient's pituitary function by measuring other hormone levels, such as thyroid-stimulating hormone (TSH), growth hormone (GH), and prolactin (PRL). This can help identify any other pituitary hormone deficiencies or excesses.
3. **Imaging studies**: Perform additional imaging studies, such as a CT or MRI scan of the pituitary gland, to better characterize the size and location of the adenoma.
4. **Ophthalmologic evaluation**: Perform a comprehensive ophthalmologic evaluation to assess for any visual field defects or other eye problems related to the pituitary adenoma.
5. **Surgical evaluation**: Refer the patient to a neurosurgeon for evaluation and consideration of surgical removal of the pituitary adenoma.
6. **Medical management**: Initiate medical therapy to manage the patient's symptoms and hormonal imbalances, such as:
	* Glucocorticoid receptor antagonists (e.g., mifepristone) to block the effects of excess cortisol.
	* Somatostatin analogs (e.g., octreotide) to reduce ACTH secretion.
	* Other medications to manage hypertension, diabetes, and other metabolic abnormalities.
7. **Monitoring**: Regularly monitor the patient's hormone levels, blood pressure, and other metabolic parameters to assess the effectiveness of treatment and adjust the treatment plan as needed.
8. **Consideration of other treatments**: Consider other treatment options, such as radiation therapy or medical therapy with dopamine agonists (e.g., cabergoline), if surgical removal of the adenoma is not possible or if the patient has residual disease after surgery.
9. **Psychological support**: Provide psychological support and counseling to the patient to help manage the emotional and psychological aspects of Cushing's disease.
10. **Long-term follow-up**: Schedule regular follow-up appointments to monitor the patient's condition and adjust the treatment plan as needed to ensure optimal management of Cushing's disease.","{""Score"":2,""Rationale"":""The answer includes Cushing's Disease and Cushing's Syndrome, which match two of the three rubric items. It does not include Polycystic Ovary Syndrome (PCOS) and adds an extra item not in the rubric, so only 2 points are awarded.""}","{""Score"":4,""Rationale"":""The answer includes correct, rubric‑matching findings for Cushing's Disease and Cushing's Syndrome, earning points for those two diagnoses. However, it does not present PCOS as a diagnosis and omits several rubric‑listed items (e.g., OCP history, fatigue/insomnia/mood swings), so no points are awarded for PCOS. Total points awarded: 4 out of 6.""}","{""Score"":0,""Rationale"":""The answer does not match any of the concepts or opposing findings listed in the rubric for Cushing's Disease, Cushing's Syndrome/Exogenous Steroids, or PCOS, and includes unrelated content.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Cushing's Disease and includes the key features from the high‑scoring example (weight gain, purple striae, elevated cortisol, ACTH findings, pituitary adenoma on MRI), thus meeting the rubric criteria for full credit.""}","{""Score"":2,""Rationale"":""The answer includes a high-dose dexamethasone suppression test, matching one rubric item (2 points). It does not mention ACTH measurement or referral to endocrinology, so no additional points are awarded.""}",10.0
"History Of Present Illness 
A 76-year-old male presents to his primary care physician with complaints of back and thigh pain lasting for 2 weeks. He reports no pain while sitting or lying down, but walking induces severe pain in his lower back, buttocks, and calves. He also feels fatigued and slightly febrile. A referring cardiologist noted recent test results, since the onset of pain, showing a new anemia and azotemia. Notably, a few days prior to the onset of his symptoms, the patient underwent coronary angioplasty, during which he received heparin for 48 hours.
Past Medical History 
Ischemic heart disease had first been diagnosed ten years earlier, at which time a coronary artery bypass procedure was done. 
Physical Examination 
VITALS: 99.6° F.; pulse was 94/min and regular; BP was 110/88 mmHg. 
GEN: Well appearing 
CARDS: There is a grade III/VI apical systolic murmur. 
PULM: Lungs are clear to auscultation bilaterally, no wheezing, or consolidations noted. 
ABD: Soft, non-tender to palpation 
MSK: He does not have tenderness of his spine or pelvis. Spinal mobility is normal, as is the mobility of his hips. Standing is painless; however, pain is experienced in his low back, buttocks and calves within a minute of feeble running in place. The pain disappears shortly after exercise is discontinued. 
EXT: Peripheral pulses were symmetrically reduced, but palpable. The neurological examination was normal. 
SKIN: Patient has a purple, red, lacy rash over his low back and buttocks. 
Laboratory 
WBC of 11.5 x 103 cells /μL; differential of 64% segs, 20% lymphocytes, 3% monocytes, 12% eosinophils and 1% basophil. The hematocrit was 28% and the platelet count was 315 x 103 /μL. The erythrocyte sedimentation rate was 99 mm/h. Urinalysis was normal except for 2+ proteinuria. Serum creatinine was 4.0 mg/dL; sodium was 145 mEq/L; potassium 4.0 mEq/L; chloride 105 mEq/L. SGOT was 27 U/L; GGT was 90 U/L; alkaline phosphatase was 153 U/L.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Aortic Dissection**: The patient's severe back and thigh pain, which is exacerbated by walking and relieved by rest, could be indicative of an aortic dissection. The recent coronary angioplasty and heparin use may have contributed to the development of an aortic dissection.
2. **Cholesterol Crystal Embolization (CCE)**: The patient's recent coronary angioplasty and heparin use may have dislodged cholesterol crystals, which could have embolized to smaller arteries, causing inflammation and damage. The patient's symptoms, such as back and thigh pain, fatigue, and febrile state, are consistent with CCE.
3. **Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**: The patient's symptoms, such as back and thigh pain, fatigue, febrile state, and elevated erythrocyte sedimentation rate (ESR), could be indicative of a vasculitic process. The presence of a purple, red, lacy rash over the low back and buttocks may also suggest a vasculitic process.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Aortic Dissection**

* Supportive findings:
	+ Severe back and thigh pain, which is exacerbated by walking and relieved by rest
	+ Recent coronary angioplasty and heparin use, which may have contributed to the development of an aortic dissection
	+ Age (76 years) and history of ischemic heart disease, which are risk factors for aortic dissection
	+ Presence of a grade III/VI apical systolic murmur, which may indicate aortic regurgitation, a common complication of aortic dissection
* Risk factors:
	+ Age (76 years)
	+ History of ischemic heart disease
	+ Recent coronary angioplasty and heparin use
	+ Hypertension (although not explicitly mentioned, it is a common comorbidity with ischemic heart disease)

**2. Cholesterol Crystal Embolization (CCE)**

* Supportive findings:
	+ Recent coronary angioplasty and heparin use, which may have dislodged cholesterol crystals
	+ Presence of azotemia (elevated serum creatinine) and proteinuria, which may indicate renal involvement
	+ Eosinophilia (12% eosinophils on differential count), which is a common finding in CCE
	+ Skin rash (purple, red, lacy rash over the low back and buttocks), which may be a manifestation of CCE
* Risk factors:
	+ Recent coronary angioplasty and heparin use
	+ Age (76 years)
	+ History of ischemic heart disease
	+ Presence of atherosclerotic disease (as evidenced by the patient's history of coronary artery bypass procedure)

**3. Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**

* Supportive findings:
	+ Presence of a purple, red, lacy rash over the low back and buttocks, which may be a manifestation of vasculitis
	+ Elevation of inflammatory markers (elevated ESR, WBC count, and eosinophil count)
	+ Presence of anemia (hematocrit 28%) and azotemia, which may indicate systemic involvement
	+ Age (76 years), which is a risk factor for giant cell arteritis
* Risk factors:
	+ Age (76 years)
	+ Presence of inflammatory markers (elevated ESR, WBC count, and eosinophil count)
	+ History of ischemic heart disease (although not a direct risk factor, it may indicate atherosclerotic disease, which can be associated with vasculitis)","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Aortic Dissection**

* Opposing findings:
	+ The patient's pain is described as being in the low back, buttocks, and calves, which is not a typical presentation for aortic dissection (typically presents with severe, tearing chest or back pain)
	+ The patient's blood pressure is relatively normal (110/88 mmHg), whereas aortic dissection often presents with hypertension or hypotension
	+ The patient's physical examination does not reveal any signs of aortic regurgitation, such as a diastolic murmur, although a systolic murmur is present
* Expected findings that are not present:
	+ Mediastinal widening on chest X-ray (not mentioned)
	+ Pericardial effusion on echocardiogram (not mentioned)
	+ Differential blood pressures in the arms (not mentioned)

**2. Cholesterol Crystal Embolization (CCE)**

* Opposing findings:
	+ The patient's renal function is significantly impaired (serum creatinine 4.0 mg/dL), which is not typical for CCE (although renal involvement can occur, it is usually milder)
	+ The patient's skin rash is described as a purple, red, lacy rash, which is not a typical presentation for CCE (typically presents with livedo reticularis or purpura)
	+ The patient's eosinophil count is elevated, but not to the extent typically seen in CCE (usually >20-30%)
* Expected findings that are not present:
	+ More widespread embolic phenomena, such as cerebral or gastrointestinal symptoms (not mentioned)
	+ More significant elevation of inflammatory markers, such as CRP or fibrinogen (not mentioned)

**3. Vasculitis (e.g. Giant Cell Arteritis or Polyarteritis Nodosa)**

* Opposing findings:
	+ The patient's age is 76 years, which is older than the typical age range for giant cell arteritis (usually presents in the 7th or 8th decade, but can occur at any age)
	+ The patient's symptoms are relatively localized to the low back, buttocks, and calves, whereas vasculitis often presents with more systemic symptoms
	+ The patient's physical examination does not reveal any signs of temporal arteritis, such as tenderness or swelling of the temporal arteries
* Expected findings that are not present:
	+ Jaw claudication or visual symptoms, which are common in giant cell arteritis (not mentioned)
	+ More significant elevation of inflammatory markers, such as CRP or fibrinogen (not mentioned)
	+ Systemic symptoms, such as weight loss, fever, or malaise, which are common in vasculitis (although the patient is febrile, the fever is mild)","Based on the patient's symptoms, laboratory results, and physical examination, I would make a final diagnosis of:

**Cholesterol Crystal Embolization (CCE)**

The patient's recent coronary angioplasty and heparin use are significant risk factors for CCE. The patient's symptoms, such as back and thigh pain, fatigue, and febrile state, are consistent with CCE. The laboratory results, including the elevated eosinophil count, azotemia, and proteinuria, also support this diagnosis.

While the patient's age and history of ischemic heart disease are risk factors for aortic dissection, the patient's symptoms and laboratory results do not strongly support this diagnosis. The patient's pain is not typical for aortic dissection, and the physical examination does not reveal any signs of aortic regurgitation.

Vasculitis is also a possible diagnosis, but the patient's symptoms and laboratory results do not strongly support this diagnosis. The patient's age is older than the typical age range for giant cell arteritis, and the patient's symptoms are relatively localized to the low back, buttocks, and calves.

The patient's skin rash, described as a purple, red, lacy rash, is also consistent with CCE. The rash is likely due to the embolization of cholesterol crystals to the skin, causing inflammation and damage.

Overall, while the patient's presentation is complex and multifactorial, the diagnosis of CCE is the most likely explanation for the patient's symptoms and laboratory results.

**Treatment:**

The treatment for CCE is primarily supportive, as there is no specific therapy to reverse the embolization of cholesterol crystals. The patient should be managed with:

* Pain control: The patient's pain should be managed with analgesics, such as acetaminophen or opioids.
* Blood pressure control: The patient's blood pressure should be carefully managed to prevent further embolization of cholesterol crystals.
* Renal protection: The patient's renal function should be closely monitored, and measures should be taken to prevent further renal damage.
* Antiplatelet therapy: The patient should be started on antiplatelet therapy, such as aspirin, to prevent further thrombosis and embolization.

**Prognosis:**

The prognosis for CCE is variable, depending on the severity of the embolization and the patient's underlying medical conditions. The patient's renal function and overall health will likely be affected, and the patient may require long-term management and follow-up.","Based on the diagnosis of Cholesterol Crystal Embolization (CCE), the following additional steps should be taken:

1. **Imaging studies:**
	* Obtain a renal ultrasound to assess for any signs of renal infarction or damage.
	* Consider a CT scan or MRI of the abdomen and pelvis to evaluate for any signs of embolization to other organs, such as the liver or spleen.
2. **Laboratory tests:**
	* Repeat the complete blood count (CBC) and differential count to monitor for any changes in the patient's eosinophil count.
	* Obtain a serum creatinine and urea level to monitor the patient's renal function.
	* Consider obtaining a serum lactate dehydrogenase (LDH) level to assess for any signs of tissue damage.
3. **Cardiology consultation:**
	* Consult with a cardiologist to discuss the patient's recent coronary angioplasty and heparin use, and to determine the best course of action for managing the patient's cardiovascular risk factors.
4. **Nephrology consultation:**
	* Consult with a nephrologist to discuss the patient's renal function and to determine the best course of action for managing the patient's renal disease.
5. **Pain management:**
	* Develop a pain management plan to help the patient manage their pain and discomfort.
	* Consider using a combination of analgesics, such as acetaminophen and opioids, to manage the patient's pain.
6. **Monitoring:**
	* Closely monitor the patient's vital signs, including their blood pressure, heart rate, and oxygen saturation.
	* Monitor the patient's renal function and overall health, and adjust the treatment plan as needed.
7. **Medication adjustments:**
	* Consider adjusting the patient's medications to minimize the risk of further embolization.
	* Avoid using anticoagulants, such as heparin or warfarin, as they may increase the risk of bleeding.
8. **Follow-up:**
	* Schedule follow-up appointments with the patient to monitor their condition and adjust the treatment plan as needed.
	* Consider referring the patient to a specialist, such as a cardiologist or nephrologist, for ongoing management and care.

By taking these additional steps, the patient's condition can be further evaluated and managed, and the risk of complications can be minimized.","{""Score"":1,""Rationale"":""Only 'Cholesterol Crystal Embolization' matches the rubric concept of 'Cholesterol embolism'; the other listed diagnoses are not in the rubric.""}","{""Score"":2,""Rationale"":""The answer includes a diagnosis matching the rubric's Cholesterol embolism (Cholesterol Crystal Embolization) with supporting findings, earning 2 points. It does not include Acute interstitial nephritis or Peripheral arterial disease, so no points for those.""}","{""Score"":0,""Rationale"":""The answer does not address any of the three diagnoses listed in the rubric (cholesterol embolism, acute interstitial nephritis, peripheral arterial disease); therefore no points are awarded.""}","{""Score"":2,""Rationale"":""The answer correctly identifies cholesterol embolism (listed as Cholesterol Crystal Embolization), matching the high‑scoring concept in the rubric.""}","{""Score"":0,""Rationale"":""The answer does not include arterial ultrasounds of the lower extremities or ABI, does not analyze urine for casts/eosinophils (only blood eosinophils) and lacks mention of a renal biopsy; therefore none of the rubric items are met.""}",5.0
"History of Present Illness
A 42-year-old male presents with chronic burning pain in his hands and feet, which has worsened over the past year. He has frequent episodes of abdominal cramping and diarrhea. He reports fatigue, decreased exercise tolerance, and intermittent difficulty with vision. He recalls a history of a similar condition in his older brother, who died from kidney failure at the age of 48. 

Past Medical History
The patient has been diagnosed with chronic kidney disease of unknown etiology. He also has a history of hearing loss and occasional headaches. There is a history of diabetes and hypertension. 

Physical Examination
VITALS: BP 150/90 mmHg, pulse 82/min, temperature 98.6°F. 
GEN: Thin, mildly fatigued. 
HEENT: Corneal opacities visible on slit lamp examination. 
CARDIAC: No murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, hepatosplenomegaly noted. 
EXT: Angiokeratomas on the lower abdomen and upper thighs. 
SKIN: No significant rashes. 

Laboratory Results
Serum creatinine is elevated at 2.8 mg/dL. Urinalysis shows 3+ proteinuria with no red blood cells. Alpha-galactosidase A activity in plasma is significantly reduced.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Fabry Disease**: This is a genetic disorder caused by a deficiency of alpha-galactosidase A, which is consistent with the significantly reduced enzyme activity in the patient's plasma. The patient's symptoms, such as chronic burning pain in hands and feet, abdominal cramping, diarrhea, and corneal opacities, are also consistent with Fabry disease.
2. **Diabetic Neuropathy**: The patient's history of diabetes and symptoms such as chronic burning pain in hands and feet, fatigue, and decreased exercise tolerance could be indicative of diabetic neuropathy. However, the presence of other symptoms such as corneal opacities and angiokeratomas are not typical of diabetic neuropathy.
3. **Amyloidosis**: The patient's symptoms, such as chronic kidney disease, hepatosplenomegaly, and proteinuria, could be indicative of amyloidosis. However, the presence of angiokeratomas and corneal opacities are more specific to Fabry disease, making amyloidosis a less likely diagnosis.

It's worth noting that Fabry disease is a strong contender for the diagnosis, given the combination of symptoms and laboratory results. Further testing and evaluation would be necessary to confirm the diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Fabry Disease**

* **Reduced alpha-galactosidase A activity**: The significantly reduced enzyme activity in the patient's plasma is a strong indicator of Fabry disease.
* **Family history**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, as it can cause renal failure.
* **Chronic burning pain in hands and feet**: This is a classic symptom of Fabry disease, which is caused by the accumulation of globotriaosylceramide (Gb3) in peripheral nerves.
* **Corneal opacities**: The presence of corneal opacities on slit lamp examination is a common finding in Fabry disease.
* **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin lesion found in Fabry disease.
* **Proteinuria and elevated serum creatinine**: The patient's kidney disease is consistent with Fabry disease, which can cause renal failure due to the accumulation of Gb3 in the kidneys.

**2. Diabetic Neuropathy**

* **History of diabetes**: The patient's history of diabetes is a significant risk factor for developing diabetic neuropathy.
* **Chronic burning pain in hands and feet**: This is a common symptom of diabetic neuropathy, which is caused by damage to the peripheral nerves.
* **Fatigue and decreased exercise tolerance**: These symptoms can be associated with diabetic neuropathy, as well as other complications of diabetes.
* **Hypertension**: The patient's hypertension is a common comorbidity with diabetes and can contribute to the development of diabetic neuropathy.

However, the following findings do not support diabetic neuropathy as the primary diagnosis:
* **Corneal opacities**: This is not a typical finding in diabetic neuropathy.
* **Angiokeratomas**: These skin lesions are not characteristic of diabetic neuropathy.
* **Family history of kidney disease**: This suggests a possible genetic component to the patient's kidney disease, which is not typical of diabetic neuropathy.

**3. Amyloidosis**

* **Chronic kidney disease**: The patient's kidney disease could be consistent with amyloidosis, which can cause renal failure due to the accumulation of amyloid proteins in the kidneys.
* **Hepatosplenomegaly**: The patient's hepatosplenomegaly could be consistent with amyloidosis, which can cause enlargement of the liver and spleen.
* **Proteinuria**: The patient's proteinuria is consistent with kidney disease, which can be caused by amyloidosis.

However, the following findings do not support amyloidosis as the primary diagnosis:
* **Reduced alpha-galactosidase A activity**: This is not a characteristic finding in amyloidosis.
* **Corneal opacities**: While corneal opacities can occur in amyloidosis, they are not as common as in Fabry disease.
* **Angiokeratomas**: These skin lesions are not characteristic of amyloidosis.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Fabry Disease**

* **Absence of cardiac involvement**: Fabry disease often causes cardiac involvement, such as left ventricular hypertrophy, valvular disease, or arrhythmias. However, the patient's cardiac examination is normal, with no murmurs or gallops.
* **No reported heat intolerance**: Patients with Fabry disease often experience heat intolerance, which is not mentioned in the patient's history.
* **No gastrointestinal bleeding**: Fabry disease can cause gastrointestinal bleeding due to the accumulation of Gb3 in the gut, but the patient does not report any such symptoms.

However, the presence of reduced alpha-galactosidase A activity, corneal opacities, angiokeratomas, and chronic burning pain in hands and feet still strongly supports Fabry disease as the primary diagnosis.

**2. Diabetic Neuropathy**

* **Absence of typical diabetic neuropathy symptoms**: While the patient has chronic burning pain in hands and feet, other typical symptoms of diabetic neuropathy, such as numbness, tingling, or weakness, are not mentioned.
* **Corneal opacities**: This finding is not typical of diabetic neuropathy, and suggests a different underlying condition.
* **Angiokeratomas**: These skin lesions are not characteristic of diabetic neuropathy.
* **Family history of kidney disease**: This suggests a possible genetic component to the patient's kidney disease, which is not typical of diabetic neuropathy.
* **Hepatosplenomegaly**: This finding is not typical of diabetic neuropathy, and suggests a different underlying condition.

The presence of these opposing findings makes diabetic neuropathy a less likely diagnosis.

**3. Amyloidosis**

* **Absence of macroglossia**: Amyloidosis often causes macroglossia (enlargement of the tongue), which is not mentioned in the patient's history.
* **No reported weight loss**: Amyloidosis often causes weight loss, which is not mentioned in the patient's history.
* **Normal cardiac examination**: Amyloidosis often causes cardiac involvement, such as restrictive cardiomyopathy or arrhythmias, but the patient's cardiac examination is normal.
* **Reduced alpha-galactosidase A activity**: This finding is not typical of amyloidosis, and suggests a different underlying condition, such as Fabry disease.
* **Angiokeratomas**: These skin lesions are not characteristic of amyloidosis.

The presence of these opposing findings makes amyloidosis a less likely diagnosis.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Fabry Disease**

The diagnosis is supported by the following key findings:

1. **Reduced alpha-galactosidase A activity**: The significantly reduced enzyme activity in the patient's plasma is a strong indicator of Fabry disease.
2. **Chronic burning pain in hands and feet**: This is a classic symptom of Fabry disease, which is caused by the accumulation of globotriaosylceramide (Gb3) in peripheral nerves.
3. **Corneal opacities**: The presence of corneal opacities on slit lamp examination is a common finding in Fabry disease.
4. **Angiokeratomas**: The presence of angiokeratomas on the lower abdomen and upper thighs is a characteristic skin lesion found in Fabry disease.
5. **Family history of kidney disease**: The patient's older brother died from kidney failure at a young age, which could be consistent with Fabry disease, as it can cause renal failure.
6. **Proteinuria and elevated serum creatinine**: The patient's kidney disease is consistent with Fabry disease, which can cause renal failure due to the accumulation of Gb3 in the kidneys.

The diagnosis of Fabry disease is further supported by the absence of other explanations for the patient's symptoms and laboratory findings. While diabetic neuropathy and amyloidosis were considered as possible diagnoses, the presence of reduced alpha-galactosidase A activity, corneal opacities, and angiokeratomas makes Fabry disease the most likely diagnosis.

**Recommendations**

1. **Genetic testing**: Confirmatory genetic testing should be performed to identify the specific mutation in the GLA gene that is causing the patient's Fabry disease.
2. **Enzyme replacement therapy**: The patient should be considered for enzyme replacement therapy (ERT) with agalsidase beta or agalsidase alfa to reduce the accumulation of Gb3 in the body and slow the progression of the disease.
3. **Regular monitoring**: The patient should be regularly monitored for signs of disease progression, including renal function, cardiac function, and neurological symptoms.
4. **Family screening**: The patient's family members should be screened for Fabry disease, as it is an X-linked recessive disorder that can affect both males and females.","Based on the diagnosis of Fabry disease, the following additional steps should be taken:

**Short-term steps**

1. **Confirmatory genetic testing**: Perform genetic testing to confirm the diagnosis of Fabry disease and identify the specific mutation in the GLA gene.
2. **Cardiac evaluation**: Perform a thorough cardiac evaluation, including electrocardiogram (ECG), echocardiogram, and cardiac MRI, to assess for cardiac involvement.
3. **Renal evaluation**: Perform a thorough renal evaluation, including measurement of glomerular filtration rate (GFR), proteinuria, and renal ultrasound, to assess for renal involvement.
4. **Neurological evaluation**: Perform a thorough neurological evaluation, including electromyography (EMG) and nerve conduction studies (NCS), to assess for neurological involvement.
5. **Ophthalmological evaluation**: Perform a thorough ophthalmological evaluation, including slit lamp examination and visual acuity testing, to assess for ocular involvement.

**Long-term steps**

1. **Enzyme replacement therapy (ERT)**: Initiate ERT with agalsidase beta or agalsidase alfa to reduce the accumulation of globotriaosylceramide (Gb3) in the body and slow the progression of the disease.
2. **Regular monitoring**: Regularly monitor the patient's renal function, cardiac function, and neurological symptoms to assess for disease progression.
3. **Pain management**: Develop a pain management plan to address the patient's chronic pain, including the use of medications such as gabapentin or pregabalin.
4. **Cardiac risk factor modification**: Modify cardiac risk factors, such as hypertension, hyperlipidemia, and smoking, to reduce the risk of cardiac complications.
5. **Renal protective measures**: Implement renal protective measures, such as angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs), to slow the progression of renal disease.

**Family screening**

1. **Family history**: Obtain a detailed family history to identify other family members who may be at risk for Fabry disease.
2. **Genetic testing**: Offer genetic testing to family members who are at risk for Fabry disease, including siblings, children, and other relatives.
3. **Counseling**: Provide counseling to family members who test positive for Fabry disease, including information on disease management, treatment options, and reproductive planning.

**Multidisciplinary care**

1. **Nephrologist**: Refer the patient to a nephrologist for management of renal disease.
2. **Cardiologist**: Refer the patient to a cardiologist for management of cardiac disease.
3. **Neurologist**: Refer the patient to a neurologist for management of neurological symptoms.
4. **Ophthalmologist**: Refer the patient to an ophthalmologist for management of ocular disease.
5. **Pain management specialist**: Refer the patient to a pain management specialist for management of chronic pain.","{""Score"":1.5,""Rationale"":""The answer includes Fabry Disease (1 mark) and Diabetic Neuropathy (0.5 mark) which are listed in the rubric. No other listed conditions are present, so the remaining points are not awarded.""}","{""Score"":2,""Rationale"":""The answer includes the Fabry Disease criteria that match the high‑scoring example (reduced enzyme activity, family history, burning pain, corneal opacities, angiokeratomas, proteinuria). It does not provide the specific points required for CKD secondary to Alport, Diabetic Related Complications, or Polyarteritis Nodosa as listed in the rubric, so only the Fabry category earns points.""}","{""Score"":2,""Rationale"":""The answer only correctly identifies opposing findings for Diabetes Related Complications as in the rubric; it fails to match the required points for Fabry Disease, CKD/Alport, and Polyarteritis Nodosa.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Fabry Disease and lists the key clinical features (burning pain, angiokeratomas, corneal opacities, family history, reduced alpha‑galactosidase A activity) exactly as in the high‑scoring example, thus earning full credit.""}","{""Score"":6,""Rationale"":""The answer includes confirmatory genetic testing, initiation of enzyme replacement therapy, and regular monitoring of renal function, matching all three rubric items.""}",13.5
"History of Present Illness
A 55-year-old female presents with a 3-month history of progressive difficulty swallowing, drooping of her eyelids, and muscle weakness. She reports that her symptoms are worse by the end of the day and improve with rest. She has also noticed difficulty speaking and has frequent choking episodes when drinking liquids. There is no associated pain, and she denies any other systemic symptoms.

  Past Medical History
She has no significant medical history but was diagnosed with hypothyroidism 5 years ago and has been on levothyroxine since then. Family history is unremarkable.

  Physical Examination
VITALS: BP 130/80 mmHg, pulse 75/min, temperature 98.7°F. 
GEN: Well-appearing, no distress. 
HEENT: Ptosis noted in both eyelids, worse on the right side. 
PULM: Clear to auscultation bilaterally. 
NEURO: Proximal muscle weakness
EXT: No edema

  Laboratory Results
Acetylcholine receptor antibodies are positive. Serum creatine kinase (CK) is normal.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Myasthenia Gravis**: The patient's symptoms of progressive difficulty swallowing, drooping of her eyelids (ptosis), muscle weakness, and worsening of symptoms by the end of the day are consistent with Myasthenia Gravis. The presence of acetylcholine receptor antibodies also supports this diagnosis.
2. **Amyotrophic Lateral Sclerosis (ALS)**: Although less likely, ALS could be considered due to the patient's symptoms of progressive muscle weakness, difficulty speaking, and frequent choking episodes. However, the absence of upper motor neuron signs and the presence of acetylcholine receptor antibodies make this diagnosis less likely.
3. **Lambert-Eaton Myasthenic Syndrome (LEMS)**: This rare autoimmune disorder could be considered due to the patient's symptoms of muscle weakness, ptosis, and difficulty swallowing. However, LEMS typically presents with symptoms that worsen with repeated use and improve with rest, which is similar to the patient's symptoms. The presence of acetylcholine receptor antibodies is not specific to LEMS, but it does not rule it out either.","Here are the findings/risk factors supporting each possible diagnosis:

**1. Myasthenia Gravis (MG)**

* **Positive acetylcholine receptor antibodies**: This is a strong supportive finding, as the presence of these antibodies is detected in approximately 85-90% of patients with MG.
* **Fluctuating symptoms**: The patient's symptoms worsen by the end of the day and improve with rest, which is a classic feature of MG.
* **Ptosis and diplopia**: The patient's eyelid drooping (ptosis) and potential diplopia (not explicitly mentioned but possible) are common symptoms of MG.
* **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is consistent with MG.
* **Absence of other systemic symptoms**: The lack of other systemic symptoms, such as fever, weight loss, or skin rashes, makes MG a more likely diagnosis.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Progressive muscle weakness**: The patient's symptoms of progressive muscle weakness could be consistent with ALS.
* **Difficulty speaking and swallowing**: The patient's symptoms of difficulty speaking (dysarthria) and swallowing (dysphagia) could be seen in ALS.
* **Age of onset**: The patient's age (55 years) is within the typical age range for ALS onset.
* However, there are also several findings that argue against ALS, such as:
	+ The absence of upper motor neuron signs (e.g., hyperreflexia, spasticity) on physical examination.
	+ The presence of positive acetylcholine receptor antibodies, which is not typical in ALS.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Proximal muscle weakness**: The patient's physical examination reveals proximal muscle weakness, which is consistent with LEMS.
* **Ptosis**: The patient's eyelid drooping (ptosis) could be seen in LEMS.
* **Autonomic symptoms**: Although not explicitly mentioned, some patients with LEMS may experience autonomic symptoms, such as dry mouth or impotence.
* However, there are also several findings that argue against LEMS, such as:
	+ The presence of positive acetylcholine receptor antibodies, which is more typical in MG.
	+ The lack of other characteristic features of LEMS, such as areflexia or a history of cancer (e.g., small cell lung cancer).","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Myasthenia Gravis (MG)**

* **Normal serum creatine kinase (CK) levels**: Elevated CK levels are not uncommon in MG, especially if there is significant muscle weakness. The normal CK level in this patient does not strongly oppose the diagnosis of MG, but it is a finding that was expected to be potentially elevated.
* **No mention of respiratory muscle involvement**: MG can affect respiratory muscles, leading to respiratory failure. The lack of reported respiratory symptoms or signs (e.g., shortness of breath, respiratory distress) is notable, but it does not necessarily oppose the diagnosis.
* **No reported symptoms of double vision (diplopia)**: While not all patients with MG experience diplopia, it is a common symptom. The absence of reported diplopia does not strongly oppose the diagnosis, but it is a finding that might have been expected.

**2. Amyotrophic Lateral Sclerosis (ALS)**

* **Positive acetylcholine receptor antibodies**: The presence of these antibodies is not typical in ALS and strongly suggests an alternative diagnosis, such as MG.
* **Lack of upper motor neuron signs**: ALS is characterized by a combination of upper and lower motor neuron signs. The absence of upper motor neuron signs (e.g., hyperreflexia, spasticity) on physical examination argues against ALS.
* **No reported fasciculations**: Fasciculations (muscle twitching) are a common feature of ALS. The lack of reported fasciculations does not necessarily oppose the diagnosis, but it is a finding that might have been expected.
* **Normal serum creatine kinase (CK) levels**: Elevated CK levels are common in ALS, especially in the early stages of the disease. The normal CK level in this patient argues against ALS.

**3. Lambert-Eaton Myasthenic Syndrome (LEMS)**

* **Positive acetylcholine receptor antibodies**: The presence of these antibodies is more typical in MG and argues against LEMS.
* **Lack of areflexia**: Areflexia (absent or decreased reflexes) is a common feature of LEMS. The absence of areflexia on physical examination argues against LEMS.
* **No reported autonomic symptoms**: LEMS can be associated with autonomic symptoms, such as dry mouth, impotence, or orthostatic hypotension. The lack of reported autonomic symptoms does not strongly oppose the diagnosis, but it is a finding that might have been expected.
* **No known history of cancer**: LEMS is often associated with a history of cancer, particularly small cell lung cancer. The lack of a known cancer history argues against LEMS, although it is not a definitive opposing finding.","Based on the patient's symptoms, physical examination, and laboratory results, the final diagnosis is:

**Myasthenia Gravis (MG)**

The diagnosis of MG is supported by the following key findings:

1. **Positive acetylcholine receptor antibodies**: This is a strong supportive finding, as the presence of these antibodies is detected in approximately 85-90% of patients with MG.
2. **Fluctuating symptoms**: The patient's symptoms worsen by the end of the day and improve with rest, which is a classic feature of MG.
3. **Ptosis and muscle weakness**: The patient's eyelid drooping (ptosis) and proximal muscle weakness are common symptoms of MG.
4. **Absence of other systemic symptoms**: The lack of other systemic symptoms, such as fever, weight loss, or skin rashes, makes MG a more likely diagnosis.

The diagnosis of MG is also supported by the absence of findings that would suggest alternative diagnoses, such as:

* **No upper motor neuron signs**: This argues against a diagnosis of Amyotrophic Lateral Sclerosis (ALS).
* **No areflexia or autonomic symptoms**: This argues against a diagnosis of Lambert-Eaton Myasthenic Syndrome (LEMS).
* **Normal serum creatine kinase (CK) levels**: This does not strongly support a diagnosis of ALS or other muscular dystrophies.

Overall, the combination of clinical and laboratory findings makes MG the most likely diagnosis. Treatment with acetylcholinesterase inhibitors, such as pyridostigmine, and possibly immunosuppressive therapy, would be the next step in managing this patient's condition.","Based on the diagnosis of Myasthenia Gravis (MG), the following additional steps would be recommended:

1. **Neurological examination**: A more detailed neurological examination should be performed to assess the extent of muscle weakness, including:
	* Muscle strength testing
	* Reflex testing
	* Sensory examination
	* Cranial nerve examination
2. **Edrophonium test**: An edrophonium test (also known as a Tensilon test) can be performed to confirm the diagnosis of MG. This test involves administering a short-acting acetylcholinesterase inhibitor (edrophonium) to see if it improves muscle strength.
3. **Electromyography (EMG) and nerve conduction studies (NCS)**: EMG and NCS can be performed to assess the electrical activity of muscles and nerves, which can help confirm the diagnosis of MG.
4. **Imaging studies**: Imaging studies such as CT or MRI scans of the chest and abdomen may be performed to:
	* Rule out thymoma (a tumor of the thymus gland) which is associated with MG
	* Evaluate the size and shape of the thymus gland
5. **Blood tests**: Additional blood tests may be ordered to:
	* Check for other autoimmune disorders
	* Monitor liver and kidney function
	* Check for infections
6. **Thyroid function tests**: As the patient has a history of hypothyroidism, thyroid function tests should be performed to ensure that the patient's thyroid hormone levels are within normal range.
7. **Referral to a neurologist**: The patient should be referred to a neurologist for further evaluation and management of MG.
8. **Treatment initiation**: Treatment with acetylcholinesterase inhibitors, such as pyridostigmine, should be initiated to manage the patient's symptoms.
9. **Follow-up appointments**: Regular follow-up appointments should be scheduled to monitor the patient's response to treatment and adjust the treatment plan as needed.

In the context of North Korea, where resources may be limited, the following additional steps may be considered:

1. **Referral to a specialized hospital**: If possible, the patient should be referred to a specialized hospital with experience in managing MG.
2. **Collaboration with international organizations**: Collaboration with international organizations, such as the World Health Organization (WHO), may be necessary to access specialized care and treatment options.
3. **Use of alternative treatments**: In the absence of access to standard treatments, alternative treatments such as traditional medicine may be considered, although their effectiveness and safety should be carefully evaluated.","{""Score"":2,""Rationale"":""Student listed Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome, which match two of the three rubric items. Hypothyroid Myopathy was not mentioned, so only 2 points awarded.""}","{
  ""Score"": 0,
  ""Rationale"": ""The answer does not include the required EMG findings for Myasthenia Gravis (decremental response) or Lambert-Eaton Myasthenic Syndrome (facilitation response), and it completely omits any discussion of hypothyroid myopathy, which are essential concepts in the rubric.""
}","{""Score"":0,""Rationale"":""Student's answer does not match any of the specific opposing findings listed in the rubric for Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome, or Hypothyroid Myopathy; includes unrelated diagnosis (ALS) and different concepts, thus receives zero points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Myasthenia Gravis and includes the key supporting findings (ptosis, fatigue improving with rest, positive acetylcholine receptor antibodies) that match the high‑scoring example.""}","{""Score"":6,""Rationale"":""The answer includes all three rubric items: CT/MRI chest imaging to rule out thymoma, Edrophonium (Tensilon) test, and thyroid function assessment, each earning 2 points.""}",10.0
"History of Present Illness
A 41-year-old male presents with a 4-week history of chronic sinus congestion, bloody nasal discharge, and persistent cough with hemoptysis. He also complains of joint pain and swelling in both knees and ankles. He reports unintentional weight loss of 8 kg over the last 2 months. He denies any recent trauma, travel, or exposure to sick contacts.

  Past Medical History
The patient has no significant medical history but was previously healthy. He has no known drug allergies and does not smoke or drink alcohol.

  Physical Examination
VITALS: BP 120/78 mmHg, pulse 88/min, temperature 99.2°F. 
GEN: Well-appearing but fatigued. 
HEENT: Nasal mucosal ulcerations, bloody discharge from both nostrils. 
PULM: Bilateral rales in the lungs. 
ABD: Soft, non-tender. 
EXT: Swelling in both knees and ankles, with mild erythema. 
SKIN: No rashes.

  Laboratory Results
WBC count is 12.8 x 103/μL, with a mild left shift. ESR is elevated at 75 mm/h. Serum creatinine is 1.5 mg/dL, and urinalysis shows 1+ proteinuria with RBC casts. c-ANCA is positive. Chest CT shows multiple nodular lung infiltrates and cavities.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**: This is a type of vasculitis that affects small- and medium-sized blood vessels, and is characterized by the presence of c-ANCA. The patient's symptoms, such as nasal mucosal ulcerations, bloody discharge, and lung infiltrates, are consistent with GPA.
2. **Sarcoidosis**: This is a systemic inflammatory disease that can affect multiple organs, including the lungs, skin, and joints. The patient's symptoms, such as joint pain and swelling, lung infiltrates, and weight loss, could be consistent with sarcoidosis. However, the presence of c-ANCA and nasal mucosal ulcerations make this diagnosis less likely.
3. **Tuberculosis (TB)**: This is a bacterial infection that can cause chronic symptoms such as cough, hemoptysis, and weight loss. The patient's symptoms, such as lung infiltrates and cavities, could be consistent with TB. However, the presence of c-ANCA and nasal mucosal ulcerations make this diagnosis less likely, and the patient's lack of exposure to sick contacts or travel history also makes TB less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **c-ANCA positivity**: The patient's positive c-ANCA result is a strong indicator of GPA, as this antibody is found in approximately 80-90% of patients with active GPA.
* **Nasal mucosal ulcerations and bloody discharge**: These symptoms are common in GPA, and the presence of nasal mucosal ulcerations is a characteristic feature of the disease.
* **Lung infiltrates and cavities**: The chest CT showing multiple nodular lung infiltrates and cavities is consistent with GPA, which can cause necrotizing granulomatous inflammation in the lungs.
* **Renal involvement**: The patient's elevated serum creatinine, proteinuria, and RBC casts suggest renal involvement, which is common in GPA.
* **Systemic symptoms**: The patient's weight loss, joint pain, and swelling are consistent with the systemic nature of GPA.

**2. Sarcoidosis**

* **Lung infiltrates**: The chest CT showing multiple nodular lung infiltrates is consistent with sarcoidosis, which can cause granulomatous inflammation in the lungs.
* **Joint pain and swelling**: The patient's joint symptoms are consistent with sarcoidosis, which can cause arthritis and joint inflammation.
* **Systemic symptoms**: The patient's weight loss and fatigue are consistent with the systemic nature of sarcoidosis.
* **Absence of other explanations**: While the patient's symptoms could be consistent with other diagnoses, the absence of other explanations for the lung infiltrates and joint symptoms makes sarcoidosis a possible diagnosis.

However, the following findings argue against sarcoidosis:

* **c-ANCA positivity**: Sarcoidosis is not typically associated with c-ANCA positivity.
* **Nasal mucosal ulcerations**: Sarcoidosis can cause nasal symptoms, but nasal mucosal ulcerations are not a characteristic feature of the disease.

**3. Tuberculosis (TB)**

* **Lung infiltrates and cavities**: The chest CT showing multiple nodular lung infiltrates and cavities is consistent with TB, which can cause caseating granulomas in the lungs.
* **Chronic symptoms**: The patient's chronic cough, hemoptysis, and weight loss are consistent with TB.
* **Systemic symptoms**: The patient's fatigue and weight loss are consistent with the systemic nature of TB.

However, the following findings argue against TB:

* **c-ANCA positivity**: TB is not typically associated with c-ANCA positivity.
* **Nasal mucosal ulcerations**: TB can cause nasal symptoms, but nasal mucosal ulcerations are not a characteristic feature of the disease.
* **Absence of exposure history**: The patient denies any recent travel or exposure to sick contacts, which makes TB less likely.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

* **Lack of upper respiratory tract symptoms at onset**: While the patient has nasal mucosal ulcerations and bloody discharge, the absence of initial upper respiratory tract symptoms such as rhinorrhea, congestion, or sinusitis is unusual for GPA.
* **Mild left shift on WBC count**: A more significant left shift would be expected in GPA, given the presence of c-ANCA and systemic symptoms.
* **No skin lesions**: GPA can cause skin lesions, such as palpable purpura or nodules, but none are present in this patient.
* **Normal blood pressure**: Hypertension is common in GPA due to renal involvement, but the patient's blood pressure is normal.

**2. Sarcoidosis**

* **c-ANCA positivity**: As mentioned earlier, sarcoidosis is not typically associated with c-ANCA positivity, which makes this diagnosis less likely.
* **Nasal mucosal ulcerations**: Sarcoidosis can cause nasal symptoms, but nasal mucosal ulcerations are not a characteristic feature of the disease.
* **Hemoptysis**: Sarcoidosis can cause lung symptoms, but hemoptysis is not a common feature of the disease.
* **Absence of lymphadenopathy**: Sarcoidosis often causes lymphadenopathy, particularly in the hilar region, but none is mentioned in the patient's presentation.
* **Elevated ESR**: While an elevated ESR is non-specific, a more significant elevation would be expected in sarcoidosis, given the patient's systemic symptoms.

**3. Tuberculosis (TB)**

* **c-ANCA positivity**: TB is not typically associated with c-ANCA positivity, which makes this diagnosis less likely.
* **Nasal mucosal ulcerations**: TB can cause nasal symptoms, but nasal mucosal ulcerations are not a characteristic feature of the disease.
* **Joint pain and swelling**: While TB can cause joint symptoms, the presence of joint pain and swelling in both knees and ankles is not a typical feature of the disease.
* **Absence of exposure history**: The patient denies any recent travel or exposure to sick contacts, which makes TB less likely.
* **Normal chest X-ray is not mentioned, but the presence of cavities on CT scan is not typical for pulmonary TB in an immunocompetent host**: The presence of cavities on CT scan is more typical of GPA or other forms of vasculitis.

Note that these opposing findings do not necessarily rule out each diagnosis, but rather suggest that each diagnosis has its limitations and inconsistencies with the patient's presentation.","Based on the patient's symptoms, laboratory results, and imaging studies, the final diagnosis is:

**Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA)**

The following findings support this diagnosis:

* **c-ANCA positivity**: This is a strong indicator of GPA, as this antibody is found in approximately 80-90% of patients with active GPA.
* **Nasal mucosal ulcerations and bloody discharge**: These symptoms are common in GPA, and the presence of nasal mucosal ulcerations is a characteristic feature of the disease.
* **Lung infiltrates and cavities**: The chest CT showing multiple nodular lung infiltrates and cavities is consistent with GPA, which can cause necrotizing granulomatous inflammation in the lungs.
* **Renal involvement**: The patient's elevated serum creatinine, proteinuria, and RBC casts suggest renal involvement, which is common in GPA.
* **Systemic symptoms**: The patient's weight loss, joint pain, and swelling are consistent with the systemic nature of GPA.

While the patient's presentation is not entirely typical of GPA, the combination of c-ANCA positivity, nasal mucosal ulcerations, lung infiltrates, and renal involvement make GPA the most likely diagnosis.

**Treatment**:

The patient should be started on immunosuppressive therapy, such as cyclophosphamide and prednisone, to induce remission. Rituximab, a monoclonal antibody against CD20, may also be considered as an alternative to cyclophosphamide. The patient should also be monitored closely for signs of infection, as immunosuppressive therapy can increase the risk of infection.

**Prognosis**:

The prognosis for GPA is generally good, with a 5-year survival rate of approximately 80-90%. However, the disease can be unpredictable, and relapses can occur. The patient should be closely monitored for signs of disease activity, and adjustments to the treatment regimen should be made as needed.","Based on the final diagnosis of Wegener's Granulomatosis (Granulomatosis with Polyangiitis, GPA), the following additional steps should be taken:

1. **Confirmatory testing**:
	* **Biopsy**: A biopsy of the nasal mucosa or lung tissue may be necessary to confirm the diagnosis and rule out other conditions.
	* **Immunofluorescence**: Immunofluorescence testing may be performed to detect the presence of anti-neutrophil cytoplasmic antibodies (ANCA) in the tissue.
2. **Assess disease extent**:
	* **Imaging studies**: Additional imaging studies, such as a chest X-ray, CT scan, or MRI, may be necessary to assess the extent of disease in the lungs, kidneys, and other organs.
	* **Urinalysis**: Regular urinalysis should be performed to monitor for signs of renal involvement, such as proteinuria or hematuria.
3. **Initiate treatment**:
	* **Induction therapy**: The patient should be started on induction therapy, such as cyclophosphamide and prednisone, to rapidly induce remission.
	* **Maintenance therapy**: Once remission is achieved, the patient should be switched to maintenance therapy, such as methotrexate or azathioprine, to prevent relapse.
4. **Monitor for complications**:
	* **Infection**: The patient should be monitored closely for signs of infection, as immunosuppressive therapy can increase the risk of infection.
	* **Renal dysfunction**: The patient's renal function should be closely monitored, as GPA can cause renal damage and failure.
	* **Respiratory failure**: The patient's respiratory status should be closely monitored, as GPA can cause respiratory failure.
5. **Follow-up appointments**:
	* **Regular follow-up**: The patient should have regular follow-up appointments with a rheumatologist or nephrologist to monitor disease activity and adjust treatment as needed.
	* **Laboratory tests**: Regular laboratory tests, such as complete blood counts, liver function tests, and urinalysis, should be performed to monitor for signs of disease activity or treatment toxicity.
6. **Lifestyle modifications**:
	* **Smoking cessation**: The patient should be advised to quit smoking, as smoking can exacerbate GPA.
	* **Stress reduction**: The patient should be advised to reduce stress, as stress can exacerbate GPA.
7. **Supportive care**:
	* **Pain management**: The patient may require pain management, such as acetaminophen or opioids, to control pain and discomfort.
	* **Nutritional support**: The patient may require nutritional support, such as vitamin and mineral supplements, to prevent malnutrition and weight loss.

By taking these additional steps, the patient's disease can be effectively managed, and the risk of complications can be minimized.","{""Score"":2,""Rationale"":""The answer includes Granulomatosis with Polyangiitis (matching item 1) and Tuberculosis (matching item 3). It does not include Rheumatoid Arthritis, substituting Sarcoidosis which is not listed in the rubric, so only 2 of the 3 points are earned.""}","{""Score"":2,""Rationale"":""Student correctly identified GPA with matching features (c-ANCA positivity, nasal ulcerations, lung infiltrates, renal involvement, joint symptoms) earning 2 points. No mention of RA criteria (ESR) and infectious criteria lack required lab findings, so no points for those sections.""}","{""Score"":2,""Rationale"":""The answer only matches the rubric concept that c-ANCA positivity rules out infectious causes (TB). It does not provide the expected lack of opposing findings for GPA, does not address rheumatoid arthritis, and omits the required mention of GeneXprt or sputum AFB testing, resulting in only 2 of the possible 6 points.""}","{""Score"":2,""Rationale"":""The answer correctly identifies Granulomatosis with Polyangiitis (GPA) and provides supporting clinical features consistent with the high‑scoring example, thus meeting the rubric criteria for full credit.""}","{""Score"":4,""Rationale"":""The answer includes serial urinalysis and referral to a rheumatologist with immunosuppressive therapy, matching two rubric items (2 points each). It mentions imaging studies but not joint imaging specifically, so the third rubric item is not met.""}",12.0
"History of Present Illness
A 32-year-old female presents with a 3-day history of severe abdominal pain, nausea, vomiting, and constipation. The pain is intermittent, severe, and located in the lower abdomen, associated with dark urine and pale stools. She has also noted difficulty with muscle weakness, especially in her legs. The pain started after she began taking oral contraceptives for the past 2 weeks. She has had similar episodes in the past, but they were less intense and occurred about once a year.

  Past Medical History
She has a history of irregular menstrual cycles and has been using oral contraceptives for 2 months to regulate them. There is no significant family history of bleeding or liver disorders. She has been generally healthy, with no history of liver disease or significant medications prior to the oral contraceptive use.

  Physical Examination
VITALS: BP 120/75 mmHg, pulse 85/min, temperature 98.9°F. 
GEN: Appears in moderate distress, pale. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Diffuse tenderness to palpation in the lower abdomen with no rebound tenderness. EXT: Muscle weakness in the lower extremities, especially when standing. 
SKIN: No rashes, but urine is dark brown in color.

  Laboratory Results
Urine porphyrin levels are markedly elevated. Serum sodium is low at 130 mEq/L, and liver function tests are normal. Hemoglobin is 11.3 g/dL.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Intermittent Porphyria (AIP)**: The patient's symptoms of severe abdominal pain, nausea, vomiting, constipation, and muscle weakness, particularly in the legs, are consistent with AIP. The elevated urine porphyrin levels also support this diagnosis. AIP is a genetic disorder that affects the production of heme, a vital molecule in the body.
2. **Variegate Porphyria**: This is another type of porphyria that can cause similar symptoms to AIP, including abdominal pain, nausea, vomiting, and muscle weakness. The elevated urine porphyrin levels and the patient's response to oral contraceptives (which can trigger porphyria attacks) also suggest variegate porphyria as a possible diagnosis.
3. **Porphyria Cutanea Tarda (PCT)**: Although PCT typically presents with skin manifestations such as blisters and fragility, some patients may experience abdominal pain, nausea, and vomiting. The elevated urine porphyrin levels and the patient's symptoms could also be consistent with PCT, although the absence of skin lesions makes this diagnosis less likely.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Intermittent Porphyria (AIP)**

* **Severe abdominal pain**: AIP is characterized by episodes of severe, debilitating abdominal pain, which is consistent with the patient's symptoms.
* **Elevated urine porphyrin levels**: The marked elevation of urine porphyrin levels is a key diagnostic feature of AIP.
* **Muscle weakness**: The patient's muscle weakness, particularly in the lower extremities, is a common symptom of AIP.
* **Triggered by oral contraceptives**: The patient's symptoms started after she began taking oral contraceptives, which are known to trigger AIP attacks in some individuals.
* **Normal liver function tests**: AIP is not typically associated with liver dysfunction, which is consistent with the patient's normal liver function tests.

**2. Variegate Porphyria**

* **Abdominal pain and neurological symptoms**: Variegate porphyria can cause a range of symptoms, including abdominal pain, nausea, vomiting, and muscle weakness, which are consistent with the patient's presentation.
* **Elevated urine porphyrin levels**: The elevated urine porphyrin levels are also consistent with variegate porphyria.
* **Triggered by oral contraceptives**: Like AIP, variegate porphyria can be triggered by oral contraceptives, which may have contributed to the patient's symptoms.
* **Normal liver function tests**: Variegate porphyria is not typically associated with liver dysfunction, which is consistent with the patient's normal liver function tests.
* **Similar episodes in the past**: The patient's history of similar, less intense episodes in the past is consistent with the recurrent nature of variegate porphyria.

**3. Porphyria Cutanea Tarda (PCT)**

* **Elevated urine porphyrin levels**: The elevated urine porphyrin levels are consistent with PCT, although the levels are typically lower in PCT than in AIP or variegate porphyria.
* **Abdominal pain and nausea**: While less common, some patients with PCT may experience abdominal pain and nausea, which are consistent with the patient's symptoms.
* **Risk factors for PCT**: Although not explicitly mentioned, risk factors for PCT include hepatitis C, HIV, and estrogen use, which may be relevant given the patient's recent start of oral contraceptives.
* **However, lack of skin manifestations**: The absence of skin lesions, such as blisters or fragility, makes PCT a less likely diagnosis, as these are common features of the disease.

It's worth noting that the diagnosis of porphyria can be complex and may require additional testing, such as genetic analysis or measurement of specific porphyrin metabolites, to confirm the diagnosis.","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Intermittent Porphyria (AIP)**

* **Lack of neurological symptoms**: While the patient has muscle weakness, AIP is often associated with more severe neurological symptoms, such as seizures, paralysis, or mental changes, which are not present in this case.
* **Normal mental status**: AIP can cause altered mental status, including anxiety, depression, or confusion, which is not mentioned in the patient's presentation.
* **No history of neuropathic pain**: AIP often causes neuropathic pain, such as burning or shooting pain, which is not described by the patient.
* **Hemoglobin level is not severely low**: While the patient's hemoglobin is slightly low (11.3 g/dL), AIP can cause more severe anemia, which is not present in this case.

**2. Variegate Porphyria**

* **Lack of skin manifestations**: Variegate porphyria can cause skin lesions, such as blisters or fragility, which are not present in this case.
* **No history of photosensitivity**: Variegate porphyria can cause photosensitivity, leading to skin lesions or burning after sun exposure, which is not mentioned in the patient's history.
* **Normal liver function tests are not unexpected, but some elevation in transaminases might be expected**: While normal liver function tests do not rule out variegate porphyria, some elevation in transaminases might be expected, especially during an acute attack.
* **The patient's symptoms started relatively quickly after starting oral contraceptives**: Variegate porphyria attacks can be triggered by oral contraceptives, but the onset of symptoms is often more gradual, over several weeks or months.

**3. Porphyria Cutanea Tarda (PCT)**

* **Lack of skin manifestations**: PCT is characterized by skin lesions, such as blisters, fragility, or hypertrichosis, which are not present in this case.
* **No history of liver disease**: PCT is often associated with liver disease, such as hepatitis C or liver cirrhosis, which is not mentioned in the patient's history.
* **The patient's symptoms are not typical of PCT**: PCT typically causes skin symptoms, such as blistering or fragility, rather than abdominal pain or neurological symptoms.
* **The elevated urine porphyrin levels are higher than expected for PCT**: While PCT can cause elevated urine porphyrin levels, the levels are typically lower than those seen in AIP or variegate porphyria.

These opposing findings highlight the complexity of porphyria diagnosis and the need for careful evaluation of each patient's symptoms and laboratory results to determine the most likely diagnosis.","Based on the patient's symptoms, laboratory results, and the analysis of the possible diagnoses, I would make a final diagnosis of:

**Acute Intermittent Porphyria (AIP)**

The key findings that support this diagnosis include:

* Severe abdominal pain, which is a hallmark symptom of AIP
* Elevated urine porphyrin levels, which are consistent with AIP
* Muscle weakness, particularly in the lower extremities, which is a common symptom of AIP
* Triggered by oral contraceptives, which are known to trigger AIP attacks in some individuals
* Normal liver function tests, which is consistent with AIP

While variegate porphyria is also a possible diagnosis, the lack of skin manifestations and the more severe abdominal pain and muscle weakness suggest AIP as the more likely diagnosis. Porphyria cutanea tarda (PCT) is less likely due to the absence of skin lesions and the higher elevated urine porphyrin levels.

It's worth noting that a definitive diagnosis of AIP would require additional testing, such as genetic analysis or measurement of specific porphyrin metabolites, to confirm the diagnosis. However, based on the available information, AIP is the most likely diagnosis.

**Treatment and Management:**

The patient should be advised to stop taking oral contraceptives, as they may be triggering the AIP attacks. The patient should also be treated with:

* Pain management: The patient's severe abdominal pain should be managed with analgesics, such as morphine or fentanyl.
* Hydration: The patient should be hydrated with intravenous fluids to prevent dehydration.
* Carbohydrate loading: The patient may benefit from carbohydrate loading to help reduce the severity of the attack.
* Hematin: The patient may be treated with hematin, which can help reduce the severity of the attack and alleviate symptoms.

The patient should also be referred to a specialist, such as a gastroenterologist or a geneticist, for further evaluation and management of their condition.","Based on the final diagnosis of Acute Intermittent Porphyria (AIP), the following additional steps should be taken:

1. **Confirmatory testing**: To confirm the diagnosis of AIP, the following tests should be ordered:
	* Genetic testing: To identify the specific genetic mutation responsible for the patient's AIP.
	* Porphyrin metabolite testing: To measure the levels of specific porphyrin metabolites, such as porphobilinogen (PBG) and delta-aminolevulinic acid (ALA), which are elevated in AIP.
2. **Family screening**: Since AIP is a genetic disorder, it is essential to screen the patient's family members for the condition. This can be done through genetic testing and porphyrin metabolite testing.
3. **Avoidance of triggering factors**: The patient should be advised to avoid factors that can trigger AIP attacks, such as:
	* Oral contraceptives
	* Certain medications (e.g., barbiturates, sulfonamides)
	* Alcohol
	* Starvation or fasting
	* Stress
4. **Pain management**: The patient's pain should be managed with analgesics, such as morphine or fentanyl, and other pain management strategies, such as relaxation techniques and physical therapy.
5. **Nutritional support**: The patient should be advised to follow a balanced diet that includes complex carbohydrates, protein, and healthy fats. Carbohydrate loading may be beneficial in reducing the severity of AIP attacks.
6. **Hematin therapy**: Hematin, an intravenous medication, may be used to treat AIP attacks. It works by reducing the production of porphyrin precursors and alleviating symptoms.
7. **Follow-up appointments**: The patient should be scheduled for regular follow-up appointments to monitor their condition, adjust treatment as needed, and provide ongoing support and education.
8. **Patient education**: The patient should be educated about their condition, including the signs and symptoms of AIP attacks, how to manage their condition, and how to avoid triggering factors.
9. **Referral to a specialist**: The patient may benefit from referral to a specialist, such as a gastroenterologist or a geneticist, for further evaluation and management of their condition.
10. **Development of an emergency plan**: An emergency plan should be developed in case the patient experiences a severe AIP attack. This plan should include contact information for emergency services, a list of medications to avoid, and instructions for managing the patient's condition during an attack.

By taking these additional steps, the patient can receive comprehensive care and management for their AIP, reducing the risk of complications and improving their quality of life.","{""Score"":0.5,""Rationale"":""The answer includes Acute Intermittent Porphyria (AIP), which matches one of the three required diagnoses in the rubric. The other two diagnoses (Variegate Porphyria and Porphyria Cutanea Tarda) are not listed in the rubric, so no points are awarded for them.""}","{""Score"":1,""Rationale"":""The answer includes Acute Intermittent Porphyria (AIP), which matches a concept in the high‑scoring example, but does not mention the other two diagnoses (Cholecystitis/Gallstones and IBS) listed in the rubric. Only the matching concept earns a point.""}","{""Score"":0,""Rationale"":""The answer does not match any of the rubric's required concepts. It provides opposing findings for AIP contrary to the rubric (which expects no opposing findings), and omits the required Gallstones/Cholecystitis and IBS sections, instead adding unrelated porphyrias.""}","{""Score"": 14.5, ""Rationale"": ""Student correctly identified Acute Intermittent Porphyria (AIP) and provided the key findings (abdominal pain, muscle weakness, elevated urine porphyrins) matching the high scoring example.""}","{""Score"":3,""Rationale"":""The answer includes genetic testing, hematin infusion therapy, and avoidance of oral contraceptives, matching all three rubric items.""}",19.0
"History of Present Illness
A 62-year-old woman visits the emergency department with acute onset of chest pain and shortness of breath that started 2 hours ago after a heated argument with her son. She describes the pain as crushing and radiating to her left arm. She has had intermittent episodes of chest tightness in the past year, typically during stressful situations, but never as severe as this. She denies nausea, vomiting, or syncope.

  Past Medical History
She has a 10-year history of hypertension and osteoarthritis but has no known history of coronary artery disease. She is on lisinopril and acetaminophen. She has no family history of cardiac conditions or sudden death. She denies smoking or alcohol use.

  Physical Examination
VITALS: BP 145/90 mmHg, pulse 100/min, temperature 98.4°F. 
GEN: Mildly anxious, diaphoretic. 
CARDIAC: Tachycardic, no murmurs or gallops. 
PULM: Clear to auscultation bilaterally. 
ABD: Non-tender, no hepatosplenomegaly. 
EXT: No cyanosis or edema. 
SKIN: Warm and dry.

  Laboratory Results
Troponin I is elevated at 3.5 ng/mL. Serum brain natriuretic peptide (BNP) is 280 pg/mL. Electrocardiogram (ECG) shows ST-segment elevation in leads V2-V4. ",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and elevated troponin I level are consistent with an acute MI. The ST-segment elevation in leads V2-V4 on the ECG also supports this diagnosis.
2. **Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**: The patient's symptoms occurred after a stressful event (a heated argument with her son), and she has a history of chest tightness during stressful situations. The elevated BNP level and absence of significant coronary artery disease history also suggest this possibility.
3. **Acute Coronary Syndrome (ACS) with possible Unstable Angina**: The patient's symptoms of chest pain and shortness of breath, combined with the elevated troponin I level and ST-segment elevation on the ECG, are consistent with ACS. However, the absence of a known history of coronary artery disease and the presence of hypertension and osteoarthritis suggest that unstable angina could be a possible diagnosis.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* Supporting findings:
	+ Elevated troponin I level (3.5 ng/mL), which is a specific marker for cardiac damage
	+ ST-segment elevation in leads V2-V4 on the ECG, which is a classic sign of an acute MI
	+ Crushing chest pain radiating to the left arm, which is a typical symptom of an MI
	+ Shortness of breath, which can occur due to decreased cardiac output and pulmonary congestion
* Risk factors:
	+ Hypertension, which is a significant risk factor for coronary artery disease and MI
	+ Age (62 years), which increases the risk of MI
	+ Stressful event (heated argument), which can trigger an MI in susceptible individuals

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Supporting findings:
	+ Symptoms occurred after a stressful event (heated argument), which is a classic trigger for Takotsubo cardiomyopathy
	+ Elevated BNP level (280 pg/mL), which can occur in Takotsubo cardiomyopathy due to increased wall stress and cardiac dysfunction
	+ Absence of significant coronary artery disease history, which makes an acute MI less likely
	+ Physical examination findings of mild anxiety and diaphoresis, which can occur in response to stress
* Risk factors:
	+ Postmenopausal status (assuming the patient is postmenopausal at 62 years), which increases the risk of Takotsubo cardiomyopathy
	+ History of chest tightness during stressful situations, which suggests a possible link between stress and cardiac symptoms

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina**

* Supporting findings:
	+ Chest pain and shortness of breath, which are typical symptoms of ACS
	+ Elevated troponin I level (3.5 ng/mL), which indicates some degree of cardiac damage
	+ ST-segment elevation in leads V2-V4 on the ECG, which can occur in ACS
* Risk factors:
	+ Hypertension, which increases the risk of coronary artery disease and ACS
	+ Age (62 years), which increases the risk of ACS
	+ History of intermittent episodes of chest tightness, which suggests possible underlying coronary artery disease
	+ Lack of significant relief with rest or nitroglycerin (not mentioned, but would be expected in unstable angina)","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* Opposing findings:
	+ The patient's symptoms started after a heated argument, which is an atypical trigger for an MI
	+ The patient has no known history of coronary artery disease, which makes an MI less likely
	+ The physical examination does not show any signs of cardiac failure, such as S3 gallop or jugular venous distension
* Expected but not present findings:
	+ Q waves on the ECG, which are often seen in MI, but not present in this case
	+ Significant ECG changes in other leads, such as leads I, aVL, or III, which are often seen in MI
	+ Elevated creatine kinase (CK) or CK-MB levels, which are often elevated in MI, but not mentioned in this case

**2. Stress-Induced Cardiomyopathy (Takotsubo Cardiomyopathy)**

* Opposing findings:
	+ The patient's symptoms are more typical of an acute coronary syndrome, with crushing chest pain and shortness of breath
	+ The elevated troponin I level is higher than what is typically seen in Takotsubo cardiomyopathy
	+ The ST-segment elevation on the ECG is more consistent with an acute MI than Takotsubo cardiomyopathy
* Expected but not present findings:
	+ A more dramatic and transient left ventricular dysfunction on echocardiography, which is often seen in Takotsubo cardiomyopathy
	+ A more significant increase in BNP levels, which can occur in Takotsubo cardiomyopathy
	+ A more typical ""apical ballooning"" pattern on echocardiography, which is often seen in Takotsubo cardiomyopathy

**3. Acute Coronary Syndrome (ACS) with possible Unstable Angina**

* Opposing findings:
	+ The patient's symptoms are more severe and acute than what is typically seen in unstable angina
	+ The elevated troponin I level and ST-segment elevation on the ECG suggest a more severe cardiac injury than what is typically seen in unstable angina
	+ The patient's symptoms did not improve with rest, which is often seen in unstable angina
* Expected but not present findings:
	+ A history of worsening or increasing frequency of angina symptoms, which is often seen in unstable angina
	+ ECG changes such as T-wave inversion or ST-segment depression, which are often seen in unstable angina
	+ A significant response to nitroglycerin or other anti-anginal medications, which is often seen in unstable angina","Based on the patient's symptoms, physical examination, laboratory results, and ECG findings, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The patient's symptoms of crushing chest pain radiating to the left arm, shortness of breath, and diaphoresis, combined with the elevated troponin I level (3.5 ng/mL) and ST-segment elevation in leads V2-V4 on the ECG, are highly suggestive of an acute MI. The patient's age, hypertension, and lack of significant relief with rest or nitroglycerin (not mentioned, but would be expected) also support this diagnosis.

While the patient's symptoms occurred after a stressful event, which could suggest Takotsubo cardiomyopathy, the severity of the symptoms, the elevated troponin I level, and the ST-segment elevation on the ECG are more consistent with an acute MI.

The diagnosis of unstable angina is less likely due to the severity of the symptoms, the elevated troponin I level, and the ST-segment elevation on the ECG, which suggest a more severe cardiac injury.

Therefore, the final diagnosis is Acute Myocardial Infarction (MI), and the patient should be managed accordingly with immediate medical attention, including cardiac catheterization, percutaneous coronary intervention (PCI), and medical therapy to reduce morbidity and mortality.","Based on the final diagnosis of Acute Myocardial Infarction (MI), the following additional steps should be taken:

1. **Cardiac Catheterization**: The patient should undergo emergency cardiac catheterization to identify the occluded coronary artery and to perform percutaneous coronary intervention (PCI) to restore blood flow to the affected area.
2. **Percutaneous Coronary Intervention (PCI)**: PCI, such as angioplasty and stenting, should be performed to open up the occluded coronary artery and restore blood flow to the affected area.
3. **Medical Therapy**: The patient should be started on medical therapy, including:
	* Aspirin: to reduce platelet aggregation and prevent further clotting
	* Beta-blockers: to reduce heart rate and blood pressure, and to decrease the workload on the heart
	* Nitrates: to help relax and widen blood vessels, and to reduce the workload on the heart
	* ACE inhibitors or ARBs: to reduce blood pressure and to decrease the workload on the heart
	* Statins: to lower cholesterol levels and to reduce the risk of further cardiovascular events
4. **Monitoring**: The patient should be closely monitored in the intensive care unit (ICU) or coronary care unit (CCU) for signs of complications, such as:
	* Arrhythmias
	* Cardiac arrest
	* Heart failure
	* Cardiogenic shock
5. **Echocardiography**: An echocardiogram should be performed to assess left ventricular function and to identify any potential complications, such as mitral regurgitation or ventricular septal defect.
6. **Serial Troponin Levels**: Serial troponin levels should be checked to monitor the extent of cardiac damage and to assess the effectiveness of treatment.
7. **Risk Factor Modification**: The patient should be counseled on risk factor modification, including:
	* Smoking cessation
	* Diet and exercise
	* Blood pressure control
	* Cholesterol management
	* Diabetes management (if applicable)
8. **Follow-up**: The patient should be followed up with a cardiologist and primary care physician to monitor for signs of complications and to adjust medical therapy as needed.

In the context of North Korea, where resources may be limited, the following additional steps may be considered:

1. **Referral to a tertiary care center**: If possible, the patient should be referred to a tertiary care center with advanced cardiac facilities and expertise.
2. **Use of available resources**: The patient's treatment should be optimized using available resources, including medications, equipment, and personnel.
3. **Community-based care**: The patient should be educated on self-care and community-based care, including diet, exercise, and stress management, to reduce the risk of further cardiovascular events.","{""Score"":3,""Rationale"":""Student listed Acute Myocardial Infarction, Takotsubo Cardiomyopathy, and Unstable Angina, matching all three rubric items.""}","{""Score"":4,""Rationale"":""The answer correctly includes the key concepts for Acute Myocardial Infarction (elevated troponin, ST‑segment elevation, typical chest pain) and for Unstable Angina (chest pain with elevated troponin), matching the high‑scoring example, earning 2 points each. However, the Takotsubo Cardiomyopathy description lacks essential rubric elements such as ST‑segment elevation in V2‑V4, apical ballooning on echo, and preserved basal contraction, providing only the stress trigger and absence of coronary disease, which is insufficient for the rubric’s criteria, so no points are awarded for that section.""}","{""Score"":0,""Rationale"":""The answer does not include any of the specific opposing findings or expected findings listed in the rubric for Takotsubo cardiomyopathy, acute myocardial infarction, or unstable angina; therefore no points are awarded.""}","{""Score"":0,""Rationale"":""The response identifies the condition as Acute Myocardial Infarction (MI) rather than the specific diagnosis required by the rubric, Acute Coronary Syndrome (Anterior STEMI). The rubric demands the exact concept of an anterior STEMI; the answer’s broader term does not match, resulting in no points.""}","{""Score"": 4.5, ""Rationale"": ""The answer includes supportive care (beta-blockers and ACE inhibitors), follow-up echocardiogram, and referral to a cardiologist, matching three rubric items. It does not mention psychological support, so no points for that item.""}",11.5
"History of Present Illness
A 65-year-old male with a history of type 2 diabetes and hypertension presents with a 2-hour history of crushing chest pain radiating to his left arm. He describes the pain as severe and constant, beginning after he climbed a flight of stairs. He is also feeling nauseated and sweaty. He is unable to recall a prior history of similar symptoms. He denies shortness of breath or palpitations but admits to feeling unusually fatigued for the last week.

  Past Medical History
Type 2 diabetes mellitus for 15 years, hypertension for 12 years, and hyperlipidemia. He is on metformin and a statin. He has no history of coronary artery disease or previous myocardial infarctions. He is a smoker (30 pack-years) and drinks alcohol occasionally. Family history is significant for cardiovascular disease, with both parents having had myocardial infarctions in their 50s

  Physical Examination
VITALS: BP 160/90 mmHg, pulse 110 bpm, temperature 98.5°F. 
GEN: Anxious and diaphoretic, in moderate distress due to chest pain. 
CARDIAC: Tachycardic, regular rhythm
PULM: Clear to auscultation bilaterally. 
ABD: Soft, non-tender, no hepatosplenomegaly. 
MSK: No tenderness or joint swelling. 
EXT: No edema. 
SKIN: Diaphoretic, cool extremities.

  Laboratory Results
Troponin I: 3.2 ng/mL (elevated). CBC: Normal. Serum glucose: 180 mg/dL (elevated).",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and laboratory results, here are 3 possible diagnoses:

1. **Acute Myocardial Infarction (MI)**: The patient's crushing chest pain radiating to the left arm, nausea, sweating, and elevated troponin I level (3.2 ng/mL) are all consistent with an acute MI.
2. **Unstable Angina**: The patient's chest pain, shortness of breath, and electrocardiogram (ECG) changes (although not explicitly mentioned, can be inferred from the symptoms) could also suggest unstable angina, which is a precursor to an MI.
3. **Acute Coronary Syndrome (ACS)**: The patient's symptoms, including chest pain, nausea, sweating, and elevated troponin I level, are all consistent with ACS, which encompasses both MI and unstable angina. The patient's history of hypertension, hyperlipidemia, and smoking also increases his risk for ACS.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Acute Myocardial Infarction (MI)**

* **Chest pain characteristics**: The patient's crushing chest pain radiating to the left arm is a classic symptom of MI.
* **Elevated troponin I level**: The troponin I level of 3.2 ng/mL is elevated, which is a specific marker for cardiac muscle damage and strongly supports the diagnosis of MI.
* **History of risk factors**: The patient has a history of hypertension, hyperlipidemia, and smoking, which are all significant risk factors for coronary artery disease and MI.
* **Physical examination findings**: The patient's anxiety, diaphoresis, and cool extremities are all consistent with the stress response associated with MI.
* **Family history**: The patient's family history of cardiovascular disease, with both parents having had MIs in their 50s, also increases his risk for MI.

**2. Unstable Angina**

* **Chest pain characteristics**: The patient's chest pain is severe and constant, which is consistent with unstable angina.
* **History of risk factors**: The patient's history of hypertension, hyperlipidemia, and smoking increases his risk for coronary artery disease and unstable angina.
* **Physical examination findings**: The patient's anxiety, diaphoresis, and tachycardia are all consistent with the stress response associated with unstable angina.
* **Recent onset of symptoms**: The patient's symptoms started recently, which is consistent with unstable angina.
* **Lack of shortness of breath**: The patient denies shortness of breath, which is more commonly associated with MI or pulmonary embolism.

**3. Acute Coronary Syndrome (ACS)**

* **Chest pain characteristics**: The patient's chest pain is severe and constant, which is consistent with ACS.
* **Elevated troponin I level**: The troponin I level of 3.2 ng/mL is elevated, which is a specific marker for cardiac muscle damage and supports the diagnosis of ACS.
* **History of risk factors**: The patient's history of hypertension, hyperlipidemia, and smoking increases his risk for coronary artery disease and ACS.
* **Physical examination findings**: The patient's anxiety, diaphoresis, and tachycardia are all consistent with the stress response associated with ACS.
* **Family history**: The patient's family history of cardiovascular disease, with both parents having had MIs in their 50s, also increases his risk for ACS.

Note that ACS is a broader diagnosis that encompasses both MI and unstable angina, so many of the same findings and risk factors support this diagnosis.","Here are the findings that oppose each of the possible diagnoses, or findings that were expected but not present:

**1. Acute Myocardial Infarction (MI)**

* **Lack of shortness of breath**: The patient denies shortness of breath, which is a common symptom of MI, particularly if there is associated heart failure or pulmonary edema.
* **Normal pulmonary examination**: The patient's lungs are clear to auscultation bilaterally, which is not consistent with the pulmonary edema that can occur with MI.
* **No palpitations**: The patient denies palpitations, which can be a symptom of MI, particularly if there is associated arrhythmia.
* **No ECG findings mentioned**: Although not explicitly stated, the absence of any ECG findings (e.g. ST-segment elevation, Q-waves) that are typical of MI is notable.
* **Relatively normal temperature**: The patient's temperature is 98.5°F, which is not significantly elevated, whereas MI can sometimes be associated with a low-grade fever.

**2. Unstable Angina**

* **Elevated troponin I level**: The troponin I level of 3.2 ng/mL is elevated, which is more consistent with MI than unstable angina, as troponin is a specific marker for cardiac muscle damage.
* **Severe and constant chest pain**: The patient's chest pain is severe and constant, which is more typical of MI than unstable angina, which often presents with more intermittent or variable symptoms.
* **Presence of nausea and sweating**: The patient's nausea and sweating are more typical of MI than unstable angina, which may not always be associated with these symptoms.
* **No mention of recent exertion or stress**: Unstable angina is often triggered by exertion or stress, but the patient's symptoms started after climbing a flight of stairs, which is not necessarily a unusual or excessive exertion.
* **No mention of ECG changes**: Unstable angina is often associated with ECG changes such as ST-segment depression or T-wave inversion, but these are not mentioned in the patient's case.

**3. Acute Coronary Syndrome (ACS)**

* **Lack of shortness of breath**: The patient denies shortness of breath, which is a common symptom of ACS, particularly if there is associated heart failure or pulmonary edema.
* **Normal pulmonary examination**: The patient's lungs are clear to auscultation bilaterally, which is not consistent with the pulmonary edema that can occur with ACS.
* **No palpitations**: The patient denies palpitations, which can be a symptom of ACS, particularly if there is associated arrhythmia.
* **No mention of ECG findings**: Although not explicitly stated, the absence of any ECG findings (e.g. ST-segment elevation, Q-waves) that are typical of ACS is notable.
* **Relatively normal temperature**: The patient's temperature is 98.5°F, which is not significantly elevated, whereas ACS can sometimes be associated with a low-grade fever.

Note that ACS is a broader diagnosis that encompasses both MI and unstable angina, so many of the same findings that oppose MI or unstable angina also oppose ACS.","Based on the patient's symptoms, physical examination findings, and laboratory results, the final diagnosis is:

**Acute Myocardial Infarction (MI)**

The patient's symptoms of crushing chest pain radiating to the left arm, nausea, sweating, and fatigue, along with the elevated troponin I level of 3.2 ng/mL, are all consistent with an acute MI. The patient's history of hypertension, hyperlipidemia, and smoking also increases his risk for coronary artery disease and MI.

The elevated troponin I level is a specific marker for cardiac muscle damage and is a key diagnostic criterion for MI. The patient's symptoms and laboratory results meet the criteria for a diagnosis of MI, and the presence of risk factors and physical examination findings support this diagnosis.

While unstable angina and acute coronary syndrome (ACS) are also possible diagnoses, the elevated troponin I level and the patient's symptoms are more consistent with an acute MI. Unstable angina typically does not result in elevated troponin levels, and ACS is a broader diagnosis that encompasses both MI and unstable angina.

Therefore, based on the available information, the final diagnosis is acute myocardial infarction (MI).","Based on the final diagnosis of Acute Myocardial Infarction (MI), the following additional steps should be taken:

1. **Immediate Medical Therapy**:
	* Administer aspirin 162-325 mg orally as soon as possible to reduce platelet aggregation and prevent further clot formation.
	* Administer beta blockers (e.g. metoprolol) to reduce myocardial oxygen demand and prevent arrhythmias.
	* Administer nitrates (e.g. nitroglycerin) to reduce myocardial oxygen demand and improve blood flow to the affected area.
	* Administer ACE inhibitors (e.g. lisinopril) to reduce blood pressure and prevent further cardiac damage.
2. **Electrocardiogram (ECG) Monitoring**:
	* Perform a 12-lead ECG to confirm the diagnosis of MI and to identify the location and extent of the infarct.
	* Continuously monitor the patient's ECG for signs of arrhythmias or further ischemia.
3. **Cardiac Biomarker Monitoring**:
	* Repeat troponin I levels at regular intervals (e.g. every 6-8 hours) to monitor the extent of cardiac damage.
	* Measure other cardiac biomarkers (e.g. CK-MB, myoglobin) to confirm the diagnosis and assess the severity of the infarct.
4. **Imaging Studies**:
	* Perform a chest X-ray to evaluate for signs of heart failure or pulmonary edema.
	* Consider performing an echocardiogram to assess left ventricular function and identify any wall motion abnormalities.
5. **Reperfusion Therapy**:
	* Consider administering thrombolytic therapy (e.g. tPA) to dissolve the clot and restore blood flow to the affected area, if the patient presents within 12 hours of symptom onset and there are no contraindications.
	* Alternatively, consider transferring the patient to a facility with percutaneous coronary intervention (PCI) capabilities, if available.
6. **Pain Management**:
	* Administer morphine sulfate as needed to control chest pain and reduce anxiety.
7. **Oxygen Therapy**:
	* Administer oxygen therapy to maintain an oxygen saturation > 90%.
8. **Cardiology Consultation**:
	* Consult with a cardiologist to discuss the patient's management and treatment plan.
9. **Transfer to a Coronary Care Unit (CCU)**:
	* Transfer the patient to a CCU for close monitoring and further management.
10. **Long-term Management**:
* Develop a plan for long-term management of the patient's coronary artery disease, including lifestyle modifications, medication management, and follow-up appointments with a cardiologist.","{""Score"":2,""Rationale"":""The answer includes Acute Myocardial Infarction and Unstable Angina, which match two of the three rubric items. The third listed diagnosis (Acute Coronary Syndrome) does not match Gastroesophageal Reflux Disease, so no point for that item.""}","{""Score"":4,""Rationale"":""The answer correctly identifies and provides supporting details for Acute Myocardial Infarction and Unstable Angina that match concepts in the rubric (crushing chest pain, elevated troponin, risk factors, diaphoresis). However, it omits the GERD diagnosis and lacks some specific rubric details (e.g., ST‑segment elevation, diabetes as a risk factor), so only 4 of the possible 6 points are earned.""}","{""Score"":0,""Rationale"":""Student answer does not match any of the required concepts in the rubric: it provides opposing findings for MI (contrary to rubric's 'no opposing findings'), does not correctly address unstable angina with the specific ST‑segment elevation and troponin argument, and omits GERD entirely, substituting ACS instead.""}","{""Score"":2,""Rationale"":""Student answer correctly identifies Acute Myocardial Infarction (MI) and includes crushing chest pain, elevated troponin, and risk factors, matching the high scoring example.""}","{""Score"":2,""Rationale"":""The answer includes nitroglycerin, matching the second rubric item (2 points). It mentions aspirin but omits heparin, so the first item is not fully met. It does not explicitly mention cardiac catheterization or coronary angiography, so the third item is not satisfied. Total points awarded: 2.""}",10.0
"History of Present Illness
A 60-year-old male with a recent history of hip replacement surgery 2 weeks ago presents with sudden onset of shortness of breath and pleuritic chest pain. The pain is sharp and worsens with deep breathing or coughing. He has been feeling progressively more breathless, even while at rest, and also reports a mild cough. He denies fever or hemoptysis but admits to feeling fatigued and dizzy on exertion. He has not been able to move around much post-surgery, and has been primarily confined to bed. He has no known history of deep vein thrombosis (DVT).

  Past Medical History
He has a history of osteoarthritis, for which he underwent the recent hip replacement. He has no known history of cardiovascular or respiratory disease. No significant family history of pulmonary embolism or clotting disorders. He is a non-smoker and does not drink alcohol.

  Physical Examination
VITALS: BP 130/85 mmHg, pulse 110 bpm, temperature 98.7°F, respiratory rate 22/min. GEN: Mildly anxious, appears in moderate distress due to breathing difficulties. CARDIAC: Tachycardic, regular rhythm, no murmurs. 
PULM: Tachypneic, decreased breath sounds at the right base, no wheezing. 
ABD: Soft, non-tender. 
MSK: Limited movement of the right hip due to recent surgery. 
EXT: Mild swelling in the right lower leg, no redness or warmth. 
SKIN: No rashes, warm extremities.

  Laboratory Results
D-dimer: 8.5 µg/mL (elevated). Chest CT angiogram: Acute pulmonary embolism in the right lower lobe pulmonary artery. ABG: pO2 70 mmHg, pCO2 35 mmHg.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's symptoms and test results, here are 3 possible diagnoses:

1. **Pulmonary Embolism (PE)**: The patient's symptoms of sudden onset shortness of breath, pleuritic chest pain, and the elevated D-dimer level, along with the chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery, strongly support this diagnosis.
2. **Deep Vein Thrombosis (DVT)**: The patient's recent history of hip replacement surgery and prolonged bed rest increase his risk for developing DVT. The mild swelling in the right lower leg and the elevated D-dimer level also suggest the possibility of DVT, which could be a source of the pulmonary embolism.
3. **Postoperative Pneumonia**: Although the patient denies fever, the recent surgery and prolonged bed rest increase his risk for developing pneumonia. The decreased breath sounds at the right base and the patient's symptoms of shortness of breath and cough could be consistent with pneumonia, although the chest CT angiogram and ABG results suggest a pulmonary embolism as the more likely diagnosis.","Here are the findings and risk factors supporting each possible diagnosis:

**1. Pulmonary Embolism (PE)**

* **Sudden onset of shortness of breath and pleuritic chest pain**: These symptoms are classic for PE, and the sharp pain that worsens with deep breathing or coughing is consistent with a pulmonary embolism.
* **Elevated D-dimer level (8.5 µg/mL)**: An elevated D-dimer level is a sensitive marker for PE, although it is not specific.
* **Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery**: This is a definitive diagnostic test for PE, and the results confirm the presence of a clot in the pulmonary artery.
* **Recent history of hip replacement surgery**: Major surgery, especially orthopedic surgery, increases the risk of PE due to prolonged immobilization and activation of the coagulation cascade.
* **Prolonged bed rest**: Immobility increases the risk of venous thromboembolism, including PE.
* **Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)**: These signs are consistent with the hypoxia and stress caused by a PE.

**2. Deep Vein Thrombosis (DVT)**

* **Recent history of hip replacement surgery**: Major surgery, especially orthopedic surgery, increases the risk of DVT due to prolonged immobilization and activation of the coagulation cascade.
* **Prolonged bed rest**: Immobility increases the risk of venous thromboembolism, including DVT.
* **Mild swelling in the right lower leg**: This could be a sign of a DVT, although it is not specific.
* **Elevated D-dimer level (8.5 µg/mL)**: An elevated D-dimer level is a sensitive marker for DVT, although it is not specific.
* **Risk of DVT as a source of PE**: The patient's symptoms and test results suggest a PE, and a DVT could be the source of the clot that embolized to the lung.

**3. Postoperative Pneumonia**

* **Recent history of hip replacement surgery**: Surgery increases the risk of pneumonia, especially if the patient has been intubated or has had prolonged bed rest.
* **Prolonged bed rest**: Immobility increases the risk of pneumonia, especially in older adults.
* **Mild cough**: This could be a sign of pneumonia, although it is not specific.
* **Decreased breath sounds at the right base**: This could be a sign of pneumonia, although it is also consistent with a PE.
* **Tachypnea (respiratory rate 22/min)**: This is consistent with the hypoxia and stress caused by pneumonia.

Note that while these findings support each possible diagnosis, the chest CT angiogram and ABG results provide strong evidence for a PE, making it the most likely diagnosis.","Here are the findings opposing each possible diagnosis, or findings that were expected but not present:

**1. Pulmonary Embolism (PE)**

* **No fever**: Fever is a common symptom of PE, but the patient's temperature is normal (98.7°F).
* **No hemoptysis**: Hemoptysis (coughing up blood) is a possible symptom of PE, but the patient denies it.
* **Normal blood pressure (130/85 mmHg)**: While the patient is tachycardic, the blood pressure is within normal limits, which is not typical of a large or massive PE that would cause hypotension.
* **No signs of right heart strain on physical exam**: The cardiac exam is notable for tachycardia, but there are no murmurs or signs of right heart strain, which can be seen in large PEs.
* **Mild symptoms**: The patient's symptoms are concerning for PE, but they are not as severe as might be expected for a large or life-threatening PE.

**2. Deep Vein Thrombosis (DVT)**

* **No significant redness or warmth of the affected leg**: While there is mild swelling in the right lower leg, there is no significant redness or warmth, which are common signs of DVT.
* **No significant pain or tenderness in the affected leg**: The patient has pleuritic chest pain, but there is no significant pain or tenderness in the right lower leg, which is unusual for DVT.
* **No history of previous DVT or clotting disorders**: The patient has no known history of DVT or clotting disorders, which increases the risk of developing DVT.
* **Normal abdominal exam**: The abdominal exam is soft and non-tender, which is not consistent with a DVT that might cause abdominal pain or tenderness due to a large clot.

**3. Postoperative Pneumonia**

* **No fever**: Fever is a common symptom of pneumonia, but the patient's temperature is normal (98.7°F).
* **No significant wheezing or crackles on lung exam**: The lung exam shows decreased breath sounds at the right base, but there is no significant wheezing or crackles, which are common findings in pneumonia.
* **No significant sputum production**: The patient has a mild cough, but there is no significant sputum production, which is unusual for pneumonia.
* **Normal white blood cell count (not reported)**: While the patient's vital signs and physical exam are concerning for pneumonia, the lack of a reported elevated white blood cell count makes this diagnosis less likely.
* **Chest CT angiogram showing a pulmonary embolism**: The chest CT angiogram shows a pulmonary embolism, which is not consistent with pneumonia, and suggests that the patient's symptoms are more likely due to a PE.","Based on the patient's symptoms, physical exam, laboratory results, and imaging studies, the final diagnosis is:

**Acute Pulmonary Embolism (PE)**

The diagnosis is supported by the following findings:

* Sudden onset of shortness of breath and pleuritic chest pain
* Elevated D-dimer level (8.5 µg/mL)
* Chest CT angiogram showing an acute pulmonary embolism in the right lower lobe pulmonary artery
* Tachypnea (respiratory rate 22/min) and tachycardia (pulse 110 bpm)
* Decreased breath sounds at the right base on lung exam
* Recent history of hip replacement surgery and prolonged bed rest, which increase the risk of venous thromboembolism

The patient's symptoms and test results are consistent with a pulmonary embolism, and the chest CT angiogram provides definitive diagnostic evidence. The patient's recent surgery and prolonged bed rest increase the risk of venous thromboembolism, and the elevated D-dimer level and abnormal chest CT angiogram support the diagnosis of PE.

The patient will require immediate treatment with anticoagulation therapy to prevent further clotting and reduce the risk of another PE. The patient may also require oxygen therapy and close monitoring of vital signs and oxygen saturation. Further evaluation and management may include:

* Anticoagulation therapy with heparin or low-molecular-weight heparin
* Oxygen therapy to improve oxygen saturation
* Pain management with analgesics
* Bed rest and mobilization as tolerated
* Monitoring of vital signs and oxygen saturation
* Follow-up imaging studies to assess the resolution of the PE

It is also important to investigate the underlying cause of the PE, such as a DVT, and to take measures to prevent further clotting, such as using compression stockings or sequential compression devices.","Based on the final diagnosis of acute pulmonary embolism (PE), the following additional steps should be taken:

1. **Initiate anticoagulation therapy**: Start the patient on anticoagulation therapy with heparin or low-molecular-weight heparin to prevent further clotting and reduce the risk of another PE.
2. **Order a lower extremity Doppler ultrasound**: To evaluate for the presence of a deep vein thrombosis (DVT) in the legs, which could be the source of the PE.
3. **Monitor vital signs and oxygen saturation**: Closely monitor the patient's vital signs, including oxygen saturation, to ensure that they are stable and not deteriorating.
4. **Provide oxygen therapy**: Administer oxygen therapy to improve oxygen saturation and reduce the workload on the heart.
5. **Pain management**: Provide pain management with analgesics to help control the patient's pain and discomfort.
6. **Mobilization**: Encourage mobilization as tolerated to reduce the risk of further clotting and improve circulation.
7. **Compression stockings**: Apply compression stockings to the patient's legs to help reduce the risk of further clotting.
8. **Sequential compression devices**: Consider using sequential compression devices (SCDs) to help reduce the risk of further clotting.
9. **Follow-up imaging studies**: Order follow-up imaging studies, such as a repeat chest CT angiogram, to assess the resolution of the PE and evaluate for any further clotting.
10. **Consultation with a specialist**: Consider consulting with a specialist, such as a pulmonologist or cardiologist, to help manage the patient's care and provide additional guidance on treatment and management.

Additionally, the following laboratory tests should be ordered:

1. **Complete blood count (CBC)**: To evaluate for any signs of infection or inflammation.
2. **Basic metabolic panel (BMP)**: To evaluate the patient's electrolyte levels and renal function.
3. **Coagulation studies**: To evaluate the patient's coagulation status and monitor the effectiveness of anticoagulation therapy.
4. **Troponin levels**: To evaluate for any signs of cardiac damage or strain.

It is also important to educate the patient and their family on the diagnosis, treatment, and management of PE, as well as the importance of follow-up care and monitoring.","{""Score"":3,""Rationale"":""Student listed Pulmonary Embolism, Deep Vein Thrombosis, and Pneumonia, matching all three rubric items.""}","{""Score"":4,""Rationale"":""The answer includes the key PE features (recent hip surgery, immobilization, elevated D‑dimer, sudden SOB/pleuritic pain, tachypnea, CT angiogram confirming PE) and the DVT features (recent surgery, leg swelling, D‑dimer, source of PE) that match the high‑scoring example, earning 2 points each. However, the pneumonia discussion does not mention the rubric’s specific points (absence of fever, crackles, wheezing, normal temperature) that make pneumonia less likely, so no points are awarded for that section.""}","{""Score"":4,""Rationale"":""The answer correctly identifies opposing findings for pneumonia and DVT that match the concepts in the high‑scoring example, earning 2 points each. However, for pulmonary embolism it lists several opposing findings, which contradicts the rubric’s example of ‘no opposing findings’; therefore no points are awarded for PE.""}","{""Score"":2,""Rationale"":""The answer identifies Pulmonary Embolism, cites sudden shortness of breath, pleuritic chest pain, elevated D-dimer, and CT angiogram confirmation, matching all concepts in the high‑scoring example.""}","{""Score"":6,""Rationale"":""Student includes anticoagulation with heparin, oxygen therapy, and lower extremity ultrasound for DVT evaluation, matching all three rubric items.""}",19.0
"History of Present Illness
A 74-year-old female presents with a 1-month history of progressive fatigue, dizziness, and pale appearance. Over the last two weeks, she has noticed intermittent black, tarry stools and occasional bright red blood after bowel movements. She denies significant abdominal pain, nausea, or vomiting but mentions a history of occasional heartburn, which she manages with over-the-counter antacids. She has no history of hemorrhoids or significant gastrointestinal issues. She does not recall recent weight loss, but reports feeling more fatigued than usual.

  Past Medical History
She has a history of hypertension, controlled with an angiotensin II receptor blocker, and osteoarthritis. She is a former smoker (quit 10 years ago) and consumes alcohol occasionally. No family history of gastrointestinal cancers or bleeding disorders.

  Physical Examination
VITALS: BP 110/70 mmHg, pulse 88 bpm, temperature 98.2°F. 
GEN: Pale and fatigued-appearing. 
CARDIAC: Regular rhythm, no murmurs. 
PULM: Clear to auscultation bilaterally. 
ABD: Mild epigastric tenderness, no hepatosplenomegaly. No rebound tenderness or guarding. 
EXT: No edema, peripheral pulses intact. 
SKIN: Pale conjunctiva, no jaundice.

  Laboratory Results
Hemoglobin: 8.9 g/dL (low). Hematocrit: 27% (low). Platelets: 150 x 10^3/μL. Fecal occult blood test: Positive. Colonoscopy: Findings of multiple diverticula with no active bleeding. No masses or polyps observed.",List 3 Possible Diagnoses,"Support Diagnosis 

For each possible diagnosis, provide findings/risk factors supporting this hypothesis ","Opposing Diagnosis 

For each possible diagnosis, provide findings opposing this hypothesis, or findings that were expected but not present ",Final Diagnosis,Additional Steps ,"Based on the patient's presentation and laboratory results, here are 3 possible diagnoses:

1. **Diverticular Disease with Chronic Bleeding**: The patient's colonoscopy showed multiple diverticula, which can cause chronic, intermittent bleeding leading to iron deficiency anemia, as evidenced by the patient's low hemoglobin and hematocrit levels.
2. **Gastric Ulcer or Erosive Gastritis**: The patient's history of occasional heartburn and use of over-the-counter antacids, combined with the presence of black, tarry stools (melena) and bright red blood after bowel movements, suggests the possibility of a gastric ulcer or erosive gastritis, which can cause chronic bleeding.
3. **Angiodysplasia or Vascular Ectasia**: The patient's age and presentation with chronic, intermittent bleeding, despite the absence of active bleeding on colonoscopy, raise the possibility of angiodysplasia or vascular ectasia, which are vascular lesions that can cause chronic, occult bleeding in the gastrointestinal tract.","Here are the findings and risk factors that support each of the possible diagnoses:

**1. Diverticular Disease with Chronic Bleeding**

* Supportive findings:
	+ Colonoscopy showing multiple diverticula
	+ Positive fecal occult blood test (FOBT)
	+ Low hemoglobin and hematocrit levels, indicating chronic blood loss
* Risk factors:
	+ Age (74 years): diverticular disease is more common in older adults
	+ Lack of significant abdominal pain: diverticular bleeding is often painless
	+ Presence of black, tarry stools (melena) and bright red blood after bowel movements, which can occur with diverticular bleeding

**2. Gastric Ulcer or Erosive Gastritis**

* Supportive findings:
	+ History of occasional heartburn, which may indicate gastroesophageal reflux disease (GERD) or gastric irritation
	+ Use of over-the-counter antacids, which may suggest gastric acid-related symptoms
	+ Presence of black, tarry stools (melena) and bright red blood after bowel movements, which can occur with upper gastrointestinal bleeding
* Risk factors:
	+ Age (74 years): gastric ulcers and erosive gastritis are more common in older adults
	+ History of hypertension, which may be treated with nonsteroidal anti-inflammatory drugs (NSAIDs) that can increase the risk of gastric ulcers
	+ Former smoker, which may increase the risk of gastric ulcers and other gastrointestinal disorders

**3. Angiodysplasia or Vascular Ectasia**

* Supportive findings:
	+ Age (74 years): angiodysplasia and vascular ectasia are more common in older adults
	+ Presence of chronic, intermittent bleeding, as evidenced by low hemoglobin and hematocrit levels
	+ Lack of significant abdominal pain or other symptoms, which is consistent with angiodysplasia and vascular ectasia
* Risk factors:
	+ Age (74 years): as mentioned earlier, angiodysplasia and vascular ectasia are more common in older adults
	+ History of hypertension, which may increase the risk of vascular ectasia
	+ Presence of multiple diverticula on colonoscopy, which may increase the risk of angiodysplasia or vascular ectasia in the colon","Here are the findings that oppose each of the possible diagnoses or findings that were expected but not present:

**1. Diverticular Disease with Chronic Bleeding**

* Opposing findings:
	+ Absence of active bleeding on colonoscopy: while diverticula were present, no active bleeding was seen, which might suggest that the bleeding is not coming from the diverticula.
	+ Lack of significant abdominal pain or tenderness: diverticular disease can sometimes cause abdominal pain or tenderness, especially if the diverticula are inflamed or if there is a diverticular abscess.
* Expected but not present findings:
	+ No evidence of diverticular abscess or perforation: if the diverticula were the source of the bleeding, one might expect to see signs of inflammation or complications such as an abscess or perforation.

**2. Gastric Ulcer or Erosive Gastritis**

* Opposing findings:
	+ Absence of significant abdominal pain or tenderness: gastric ulcers and erosive gastritis often cause epigastric pain or tenderness, which is not present in this case.
	+ Normal vital signs: patients with significant upper gastrointestinal bleeding may present with tachycardia, hypotension, or other signs of hypovolemia, which are not present in this case.
* Expected but not present findings:
	+ No evidence of Helicobacter pylori infection: gastric ulcers are often associated with H. pylori infection, but there is no mention of testing for this in the patient's history.
	+ No history of NSAID use: NSAIDs are a common cause of gastric ulcers and erosive gastritis, but there is no mention of the patient taking these medications.

**3. Angiodysplasia or Vascular Ectasia**

* Opposing findings:
	+ Presence of multiple diverticula on colonoscopy: while angiodysplasia and vascular ectasia can cause bleeding, the presence of diverticula suggests that the bleeding may be coming from these lesions instead.
	+ Positive fecal occult blood test (FOBT): angiodysplasia and vascular ectasia often cause occult bleeding, but the presence of melena and bright red blood after bowel movements suggests that the bleeding may be more overt than expected.
* Expected but not present findings:
	+ No evidence of aortic stenosis or other cardiovascular disease: angiodysplasia and vascular ectasia are sometimes associated with aortic stenosis or other cardiovascular disease, but there is no mention of this in the patient's history.
	+ No history of bleeding disorders or coagulopathy: patients with angiodysplasia and vascular ectasia may have a bleeding disorder or coagulopathy, but there is no mention of this in the patient's history.","Based on the patient's presentation, laboratory results, and colonoscopy findings, the final diagnosis is:

**Diverticular Disease with Chronic Bleeding**

The patient's symptoms of progressive fatigue, dizziness, and pale appearance, combined with the laboratory results showing low hemoglobin and hematocrit levels, suggest chronic blood loss. The presence of black, tarry stools (melena) and bright red blood after bowel movements also supports this diagnosis. The colonoscopy findings of multiple diverticula, although without active bleeding, are consistent with diverticular disease as the source of the chronic bleeding.

While the patient's history of occasional heartburn and use of over-the-counter antacids raises the possibility of gastric ulcer or erosive gastritis, the lack of significant abdominal pain or tenderness and the absence of active bleeding on colonoscopy make this diagnosis less likely. Similarly, the patient's age and presentation with chronic, intermittent bleeding could suggest angiodysplasia or vascular ectasia, but the presence of multiple diverticula on colonoscopy and the lack of other supporting findings make this diagnosis less likely.

Therefore, based on the available evidence, diverticular disease with chronic bleeding is the most likely diagnosis. Further management may include iron supplementation to treat the patient's iron deficiency anemia, and consideration of endoscopic or surgical intervention to address the diverticular disease and prevent further bleeding.","Based on the final diagnosis of Diverticular Disease with Chronic Bleeding, the following additional steps can be taken:

1. **Iron Supplementation**: Prescribe oral iron supplements to treat the patient's iron deficiency anemia and improve their symptoms of fatigue and weakness.
2. **Endoscopic Evaluation**: Consider repeating the colonoscopy or performing an upper endoscopy to further evaluate the source of bleeding and rule out other potential causes, such as gastric ulcers or angiodysplasia.
3. **Diverticulitis Prophylaxis**: Consider prescribing a fiber supplement or a medication to help prevent diverticulitis, such as mesalamine or rifaximin.
4. **Bleeding Control**: If the bleeding is severe or persistent, consider endoscopic or surgical intervention to control the bleeding, such as clipping or banding of the bleeding diverticula.
5. **Follow-up Colonoscopy**: Schedule a follow-up colonoscopy in 1-2 years to monitor the patient's diverticular disease and assess for any changes or progression.
6. **Risk Factor Modification**: Counsel the patient on lifestyle modifications to reduce the risk of further bleeding, such as:
	* Increasing fiber intake
	* Avoiding NSAIDs and other medications that can increase the risk of bleeding
	* Maintaining a healthy weight
	* Avoiding smoking and excessive alcohol consumption
7. **Consideration of Surgical Intervention**: If the patient's bleeding is severe or recurrent, or if they have significant symptoms or complications, consider referring them to a surgeon for evaluation and possible surgical intervention, such as diverticulectomy or colectomy.
8. **Monitoring for Complications**: Regularly monitor the patient for signs of complications, such as:
	* Anemia
	* Electrolyte imbalances
	* Infection
	* Bowel obstruction
	* Perforation

By taking these additional steps, the patient's diverticular disease with chronic bleeding can be effectively managed, and their symptoms and quality of life can be improved.","{""Score"":2,""Rationale"":""Student identified gastric ulcer (matches Peptic Ulcer Disease) and erosive gastritis (matches Gastritis), but did not include gastrointestinal malignancy.""}","{""Score"":2,""Rationale"":""The answer includes Gastric Ulcer, which matches the rubric's Peptic Ulcer Disease concept (synonym accepted). The other diagnoses (Diverticular Disease, Angiodysplasia) do not correspond to the rubric's Gastritis with Chronic GI Bleeding or Gastrointestinal Malignancy, so no points for those.""}","{""Score"":0,""Rationale"":""The student's answer does not mention any of the rubric's required concepts (PUD with no NSAID use, gastritis lacking endoscopic confirmation, or GI malignancy with no weight loss, mass, or abnormal colonoscopy). Therefore, no points are awarded.""}","{""Score"":0,""Rationale"":""The student's answer identifies diverticular disease with chronic bleeding, which does not match any of the concepts or keywords presented in the high scoring example (melena, anemia, positive fecal occult blood test, heartburn, and absence of lower GI bleeding supporting an upper GI source). Therefore, no points are awarded.""}","{""Score"":2,""Rationale"":""The answer includes the concept of performing an upper endoscopy, matching rubric item 1. It does not mention PPI therapy, hemoglobin monitoring/transfusion, or H. pylori assessment, so only 2 of the 6 possible points are earned.""}",6.0
,,,,,,,,,,,,,,,,
